All conditions

Atrial Fibrillation

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

3004
Trials on record
383
Recruiting now
6
Australian sites
13
Phase 3 trials
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Atrial Fibrillation →

Get alerts when Atrial Fibrillation trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Atrial Fibrillation

Atrial fibrillation, often called AF or AFib, is a condition where the heart beats in an irregular and sometimes fast rhythm. Normally, the heart follows a steady, organised electrical pattern to pump blood around the body. In AF, the upper chambers of the heart (called the atria) receive chaotic electrical signals, causing them to quiver rather than beat in a smooth, coordinated way. This irregular beating means the heart may not pump blood as efficiently as usual, and blood can sometimes pool and form clots, which is why AF can increase the risk of stroke.

AF is one of the most common heart rhythm conditions in Australia. It affects an estimated 500,000 or more Australians, and that number is growing as the population ages. While AF can occur in younger people, it becomes more common from middle age onwards. Some people have no symptoms at all and only find out through a routine check-up, while others notice a fluttering sensation in the chest, shortness of breath, tiredness, or dizziness.

When it comes to managing AF, doctors generally focus on a few key areas: controlling the heart rate or rhythm, and reducing the risk of stroke, often through blood-thinning medications. Some people may be offered procedures such as electrical cardioversion, which aims to reset the heart's rhythm, or a procedure called catheter ablation. Lifestyle factors such as managing weight, alcohol intake, and blood pressure are also considered important. Everyone's situation is different, so a cardiologist or GP will work with the individual to discuss what options may be appropriate for them.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Atrial Fibrillation in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

Research pipeline

Where trials for Atrial Fibrillation currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Atrial Fibrillation.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Atrial Fibrillation by country. Australia is highlighted.

Showing the top 10 of 59 countries with trial sites.

Clinical trials for Atrial Fibrillation

Showing 386 of 386 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT00911508 · Mayo Clinic Not Applicable · 10 countries Completed
Completed Not Applicable Est. completion 31 December 2017
🇦🇺 AU🇨🇦 CA🇨🇳 CN🇨🇿 CZ🇩🇪 DE🇮🇹 IT🇷🇺 RU🇰🇷 KR +2 more

**Who might be able to join this trial:** - You have had at least 2 episodes of atrial fibrillation (an irregular heartbeat) in the past 6 months, each lasting at least 1 hour, with at least one confirmed by a heart tracing (ECG); OR one longer episode lasting 7 or more days confirmed by ECG; OR one continuous episode...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT03354663 · Abbott Medical Devices Not Applicable · 4 countries Completed
Completed Not Applicable Est. completion 2 August 2018
🇦🇺 AU🇩🇪 DE🇮🇹 IT🇺🇸 US

**Who might be able to join this trial:** - You are planning to have a catheter ablation procedure because you have episodes of atrial fibrillation (an irregular heartbeat) that causes symptoms, and at least one medication meant to control heart rhythm has not worked or you could not tolerate it - Your doctor has noted...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT04356040 · Abbott Medical Devices Not Applicable · 10 countries Completed
Completed Not Applicable Est. completion 1 July 2022
🇦🇺 AU🇦🇹 AT🇨🇦 CA🇨🇿 CZ🇩🇪 DE Hong Kong🇮🇹 IT🇳🇱 NL +2 more

**Who might be able to join this trial:** - You are planning to have a catheter ablation procedure for atrial fibrillation (a heart rhythm problem) that causes symptoms - Your doctor has noted that your atrial fibrillation episodes come and go on their own - You have had at least one atrial fibrillation episode recorde...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT03968393 · Population Health Research Institute Phase 4 · 18 countries Recruiting
Recruiting Phase 4 Est. completion 1 December 2028
🇦🇷 AR🇦🇺 AU🇧🇷 BR🇨🇦 CA🇩🇰 DK🇫🇮 FI🇩🇪 DE🇮🇳 IN +10 more

**Who might be able to join this trial:** - People who had at least one episode of atrial fibrillation (an irregular heart rhythm) that occurred during or after a non-heart-related surgery or a serious illness requiring a hospital stay within the past 35 days - People whose heart is beating in a normal, regular rhythm...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
🇦🇺 NCT06324188 · Atrial Fibrillation Network Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 February 2030
🇦🇺 AU🇨🇦 CA🇩🇪 DE🇳🇱 NL🇵🇱 PL🇪🇸 ES🇬🇧 GB

Who might be able to join this trial: - People who were first diagnosed with atrial fibrillation (an irregular heart rhythm) within the last 5 years, with that diagnosis recorded on a heart tracing (ECG) taken from the surface of the skin - People who have a high number of health risk factors, measured by a scoring sys...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06455098 · Biosense Webster, Inc. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇦🇺 AU🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with symptomatic paroxysmal atrial fibrillation (AF), meaning AF episodes that come and go and cause noticeable symptoms. - People who have had at least two symptomatic AF episodes in the last six months before joining the trial. - People who have h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06735534 · Boston Scientific Corporation Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇦🇺 AU🇹🇼 TW🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older (or older if local laws require it) - People who have had exactly one previous catheter-based heart procedure (done from inside the heart) to treat atrial fibrillation (AF), which at minimum targeted the pulmonary veins (the vessels connecting the lun...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT07298473 · Medtronic Cardiac Ablation Solutions Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 29 March 2028
🇦🇺 AU🇧🇪 BE🇨🇿 CZ🇫🇷 FR🇨🇭 CH🇺🇸 US

**Who might be able to join this trial:** - People who have had exactly one previous ablation procedure for atrial fibrillation (AF) in the past 3 years - People whose AF, or a related heart rhythm problem, came back at least 90 days after their first ablation, with a doctor's note confirming at least one symptomatic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT07726056 · University Hospital of Leuven Leuven Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇦🇺 AU🇧🇪 BE

Who might be able to join this trial: - People between 18 and 80 years old - People who participate in endurance sports for at least 4 hours per week - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm condition) - People who already record their training activity using platforms such a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00921986 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2035
🇺🇸 US

Who might be able to join this trial: - People who are at least 18 years old, of any gender - People who have had or currently have a heart rhythm problem (cardiac arrhythmia), OR family members of people with a heart rhythm problem, OR people with no heart rhythm problem who would participate as a control (comparison)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02118467 · University of Chicago Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 October 2026
🇺🇸 US

Who might be able to join this trial: - You are 18 years of age or older - You are in a state of shock (dangerously low blood pressure that has not improved with fluids) and need blood pressure-supporting medications given through a central line (a tube inserted into a large vein) Who may not be able to join: - Your h...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT02138695 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2029
🇰🇷 KR

Who might be able to join this trial: - People who are scheduled to have a catheter ablation procedure for atrial fibrillation (an irregular heartbeat condition) because their symptoms have not improved with medication Who may not be able to join: - People who do not agree to take part in the study - People whose atri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02219984 · GUALTIERO PALARETI Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇮🇹 IT

Who might be able to join this trial: - People who are 18 years of age or older Who may not be able to join: - People who are under 18 years of age - People who are not willing to sign an informed consent form (a document agreeing to take part in the trial) Important: Always verify eligibility with the trial site dir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02347111 · University of Illinois at Chicago Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have a history of atrial fibrillation (an irregular heart rhythm) that comes and goes or is persistent, with symptoms occurring at least twice a month - People who have had a heart tracing (ECG) recorded within the past mo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT02699957 · American College of Cardiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇺🇸 US

"Who might be able to join this trial: - Adults aged 18 years or older who are having a procedure to close off a small pouch in the heart (called the left atrial appendage), either through a blood vessel or through the outer surface of the heart Who may not be able to join: - There are no listed exclusion criteria for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02741349 · Saint Antoine University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have non-valvular atrial fibrillation (an irregular heartbeat not caused by a heart valve problem) that is occasional, ongoing, or permanent, and has been confirmed by a heart tracing test (ECG) - People who are willing and able to s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02808260 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2034
🇨🇦 CA

Who might be able to join this trial: - People who have had a dual-chamber permanent pacemaker or defibrillator (a device with two leads implanted in the heart) fitted within the last 10 years Who may not be able to join: - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) confirmed b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02997254 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

"Who might be able to join this trial: - People aged between 21 and 80 years old who have had a heart procedure to treat an irregular heartbeat condition called Atrial Fibrillation, where doctors used a technique called ablation (which uses energy to correct the abnormal electrical signals in the heart) Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03091452 · Stiftung Institut fuer Herzinfarktforschung Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇩🇪 DE

Who might be able to join this trial: - You have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - You are being treated with a heart surgery procedure to correct the irregular heartbeat (known as surgical ablation) Who may not be able to join: - You do not wish to take part in the trial Im...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03168659 · CardioFocus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled to have a procedure called catheter ablation because they have an irregular heartbeat condition known as paroxysmal atrial fibrillation that is causing symptoms - People for whom at least one medication used to co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03243175 · University Hospital, Lille Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2029
🇫🇷 FR

**Who might be able to join this trial:** - People who are 18 years of age or older (there is no upper age limit for the general trial) - People who have a history of a type of irregular heartbeat called atrial fibrillation (paroxysmal, persistent, or long-standing), confirmed by a heart tracing (ECG) - People whose a...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03272620 · Medical University of Vienna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2020
🇦🇹 AT

Who might be able to join this trial: - You have been diagnosed with atrial fibrillation (an irregular heartbeat condition) and are being treated at the Emergency Department of the Medical University of Vienna - You have read and signed a consent form agreeing to take part in the trial Who may not be able to join: - Y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03355456 · Ohad Ziv Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have a type of irregular heartbeat called atrial fibrillation (AF) that is not the short, intermittent kind (known as "non-paroxysmal" AF) - People who have already tried at least one medication to control their heart rhythm, but it either did not work or caused s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03357926 · Medical University of Graz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇦🇹 AT

Who might be able to join this trial: - You have a pacemaker or a device called an implanted cardioverter defibrillator (ICD) that has a lead (wire) connected to the upper chamber of your heart - You have a score of 2 or more on a stroke risk assessment tool called the CHADS-VASc score (confirm with trial site) - Your...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03376165 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇫🇷 FR

Who might be able to join this trial: - People who are scheduled to have heart surgery, such as bypass surgery, valve surgery, or a minimally invasive valve replacement procedure (transcatheter valve implantation) Who may not be able to join: - People who are pregnant - People whose surgery or procedure is classified...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03397602 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇨🇦 CA

Who might be able to join this trial: - People who have persistent or permanent atrial fibrillation (an irregular heart rhythm that does not go away on its own) - People whose heart rate is controlled, with a resting heart rate of 100 beats per minute or lower - People who are able to complete an exercise test that pus...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03428048 · Cardiovascular Innovation and Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇺🇸 US

Who might be able to join this trial: - You must be over 18 years old. - You must be willing and able to understand the study details and sign a consent form agreeing to take part. - You must be available to attend follow-up appointments after joining the study. - You must have been diagnosed with either coronary arter...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03445949 · National Institute of Cardiology, Warsaw, Poland Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 23 June 2025
🇵🇱 PL

**Who might be able to join this trial:** - People who have recently had a successful procedure to close off a part of the heart called the left atrial appendage, using either an Amplatzer or WATCHMAN device, within the past 37 days before joining the study - People who have been taking two blood-thinning medications t...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03546374 · Medtronic Cardiac Surgery Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2024
🇺🇸 US

**Who might be able to join this trial:** - People who have a persistent or long-standing persistent form of atrial fibrillation (an irregular heartbeat that does not come and go but stays ongoing) - People who already need non-emergency open-heart surgery for another reason, such as a heart bypass operation or heart v...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03711539 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2021
🇧🇪 BE

**Who might be able to join this trial:** - You started doing endurance sports (triathlon, cycling, distance running of 1500 metres or longer, or rowing) **before age 30**, compete at a regional, national, or international level, are between **45 and 70 years old**, and train more than 10 hours per week (if you cycle...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03718364 · University Hospital, Basel, Switzerland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2035
🇨🇭 CH

"Who might be able to join this trial: - People who are scheduled to have a catheter-based heart procedure to treat an irregular heart rhythm called atrial fibrillation, specifically a procedure known as pulmonary vein isolation (where small areas of heart tissue are treated to stop abnormal electrical signals) Who ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03830320 · Massachusetts General Hospital Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 January 2027
🇺🇸 US

**Who might be able to join this trial:** **If you have Atrial Fibrillation (an irregular heartbeat condition):** - You have a history of atrial fibrillation (irregular heartbeat), including the type that comes and goes - You have recently had (within the last 14 days) a special heart ultrasound called a TEE to look a...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03862859 · Nicholas Carlson Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2027
🇩🇰 DK

**Who might be able to join this trial:** - People aged 18 or older who are on long-term dialysis because their kidneys have failed - People who have a type of irregular heartbeat called atrial fibrillation (either occasional, ongoing, or permanent), confirmed by a heart tracing (ECG) or a monitoring device recording...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03868150 · Stanford University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2030
🇺🇸 US

**Who might be able to join this trial:** - People scheduled for their first planned (non-emergency) open-heart surgery, such as coronary artery bypass grafting (heart bypass surgery), heart valve repair or replacement, a combination of bypass and valve surgery, or a type of aortic root repair that preserves the valve...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03907046 · Yale University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - People who are at least 18 years old - People who have had a bleed inside the brain (including bleeding into the brain's fluid-filled spaces), confirmed by a CT or MRI scan - People who can be enrolled in the trial between 14 and 180 days after their brain bleed occurred - People...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04005508 · National University of Singapore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇸🇬 SG

Who might be able to join this trial: - People aged 22 or older. - People who have been diagnosed with atrial fibrillation (an irregular heartbeat), including any type — occasional, ongoing, or continuous. - People who have at least one of the following heart or health risk factors: high blood pressure; diabetes; a his...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04240366 · University of Luebeck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇩🇪 DE

**Who might be able to join this trial:** - You have atrial fibrillation (an irregular heartbeat) that has lasted continuously for more than 7 days or more than 12 months - You are between 18 and 80 years old - Your doctor has recommended that you have a procedure (called ablation) to treat your atrial fibrillation, ba...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04247685 · Dr. Graham Wright Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - People who agree to participate and sign a consent form - People covered by the Ontario Health Insurance Plan (OHIP) **Who may not be able to join:**...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04267159 · Tampere University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇫🇮 FI

Who might be able to join this trial: - People who come to the emergency room with atrial fibrillation or atrial flutter that started less than 48 hours ago - People whose emergency room doctor is planning to treat the irregular heart rhythm acutely - People who the attending emergency room doctor considers to be in ge...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04281329 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are scheduled to have a radiofrequency procedure (a type of heart rhythm treatment) for atrial fibrillation (AF) within the next 6 months. - You are 18 years of age or older. - You are covered by a social security or health insurance scheme. - You have been fully informed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04298723 · Jena University Hospital Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇩🇪 DE🇵🇱 PL

**Who might be able to join this trial:** - People who are able and willing to give written consent to take part in the trial - People who have a confirmed diagnosis of atrial fibrillation (an irregular heart rhythm), of any type — including paroxysmal, persistent, long-standing persistent, or permanent - People with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04347187 · National Medical Research Center for Cardiology, Ministry of Health of... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇷🇺 RU

**Who might be able to join this trial:** - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) and have a stroke risk score above 1 based on a standard medical scoring system called CHA2DS2-VASc (confirm with trial site) **Who may not be able to join:** - People who are unwillin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04436978 · St. Antonius Hospital Phase 4 · 2 countries Recruiting
Recruiting Phase 4 Est. completion 1 October 2027
🇧🇪 BE🇳🇱 NL

**Who might be able to join this trial:** - People aged 18 or older - People who have recently had a successful procedure to open blocked heart arteries (called PCI, either as an emergency or planned procedure) - People who have been diagnosed with an irregular heart rhythm called atrial fibrillation or atrial flutter...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04449523 · Insel Gruppe AG, University Hospital Bern Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇦🇹 AT🇩🇪 DE🇨🇭 CH

**Who might be able to join this trial:** - People aged 65 or older, OR people aged 50 or older who also meet at least one of these additional conditions: a specific heart protein level above 400 pg/mL on a blood test (NT-proBNP), an enlarged upper-left chamber of the heart detected on imaging, or silent brain damage...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04528511 · Shanghai 10th People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who are over 18 years old - People who were hospitalised for a heart attack (either a severe type called STEMI or a less severe type called NSTEMI) and developed a new irregular heart rhythm called atrial fibrillation (AF) for the first time during that hospital stay -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04529785 · AZ Sint-Jan AV Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇧🇪 BE

**Who might be able to join this trial:** - Adults aged 18 years or older - People who are scheduled for a second heart rhythm procedure (ablation) for paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes), after having had a previous procedure to isolate the pulmonary veins - People for wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04559243 · Lifetech Scientific (Shenzhen) Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older, of any gender - People who are able to understand what the study involves, are willing to take part voluntarily, sign a consent form, and attend follow-up visits as required - People who have a medical need for a procedure to close off a part of the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04593498 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇸🇪 SE

Who might be able to join this trial: - You may be eligible if a heart monitoring test (called a Holter recording) showed that you have at least 30 irregular heartbeats per hour coming from the upper chambers of your heart, or a run of at least 20 of these irregular beats in a row. Who may not be able to join: - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04606693 · Hospital San Carlos, Madrid Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

Who might be able to join this trial: - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation, either in short episodes or as an ongoing condition - People whose atrial fibrillation has come back even after being treated with at least one heart rhythm medication - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04628078 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2023
🇨🇭 CH

Who might be able to join this trial: - Adults aged 18 or older - People with a type of irregular heartbeat called atrial fibrillation (AF) — whether it comes and goes, has lasted a long time, or is ongoing — that is not caused by a heart valve problem, and who have a stroke risk score of 2 or higher on a standard medi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04642430 · Ottawa Hospital Research Institute Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇨🇦 CA

Who might be able to join this trial: - You are 18 years of age or older - You have been recently diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing test (ECG), and your doctor has determined you need to start blood thinning medication Who may not be able to join: - Your kidneys...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04685317 · Malini Madhavan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who are scheduled to have a heart rhythm procedure (called ablation — using radiofrequency, pulsed field, or cryo-balloon methods) to treat atrial fibrillation (an irregular heartbeat), in line with current medical guidelines. - People whose atrial fi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04695106 · Medical University of Gdansk Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 11 July 2026
🇵🇱 PL

Who might be able to join this trial: - You must be 18 years old or older, either male or female. - You must have an irregular heart rhythm called atrial fibrillation (AF), which is not caused by a temporary or reversible condition (such as a recent heart attack, blood clot in the lungs, recent surgery, or thyroid prob...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04696081 · University Hospital, Caen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇫🇷 FR

**Who might be able to join this trial:** - Adults (18 years or older) - People who are either being treated as outpatients or are currently in hospital - People who have a confirmed active cancer diagnosis — meaning cancer diagnosed within the past 6 months, or cancer that has come back or spread and is currently bein...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04700826 · University of Birmingham Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) — whether in the past, currently, or as an ongoing condition - People who are aged between 55 and 73 years old at the time of joining the trial **Who may not be able to join:** - Peopl...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04701749 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2030
🇫🇷 FR

Who might be able to join this trial: - People who are over 18 years old and covered by a social security scheme. - People who have bleeding in the urine caused by bladder damage from radiation treatment, and who also have an irregular heart rhythm (called atrial fibrillation) that is not related to a heart valve probl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04703166 · Tulane University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

Who might be able to join this trial: - People who have atrial fibrillation (an irregular heartbeat condition) and are between 18 and 79 years old, OR people between 40 and 79 years old who have been assessed as being at moderate or high risk for cardiovascular disease using a standard risk calculation tool called the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04715425 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2024
🇳🇱 NL

**Who might be able to join this trial:** - People aged between 18 and 80 years old. - People who have persistent atrial fibrillation (an irregular heart rhythm that is ongoing or has required an electrical shock to reset the heart), confirmed by a heart tracing (ECG) or similar test within the past year. - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04776759 · University Hospital, Caen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2031
🇫🇷 FR

Who might be able to join this trial: - People who have had their first ever episode of atrial fibrillation (an irregular heartbeat condition) - People who are under 35 years old - People whose atrial fibrillation was confirmed by a standard heart tracing test (ECG) or by a monitoring device that recorded the irregular...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04796714 · University Hospital, Bordeaux Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 3 May 2027
🇫🇷 FR

Who might be able to join this trial: - People who have been identified as needing a left atrial appendage closure (a procedure to reduce stroke risk in people with an irregular heartbeat) based on French national medical guidelines. - People aged 18 or older. - People who have given written consent to take part in the...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04814420 · Tulane University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 75 years old. - You have been diagnosed with mild sleep apnea (breathing interruptions during sleep), confirmed by an overnight sleep study — and have **no** history of irregular heart rhythm (atrial fibrillation). - You have been diagnosed with modera...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04823299 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇨🇦 CA

Who might be able to join this trial: - People who are 18 years of age or older at the time of signing the consent form - People who have paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) with at least one episode in the past 12 months — though people already taking heart rhythm medicat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04844801 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years old or older - You have been diagnosed with or are suspected to have a serious infection, and have been started on antibiotics - You need medication to keep your blood pressure stable (specifically norepinephrine or epinephrine) and have been on it for at le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04844944 · Helios Health Institute GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇩🇪 DE

Who might be able to join this trial: - People who are 18 years of age or older - People who are currently admitted to hospital as an inpatient - People who have been diagnosed with at least one of three heart conditions: heart failure, coronary artery disease (a condition where the arteries supplying the heart become...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04880265 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - People who are scheduled for planned (non-emergency) open heart surgery - People who are older than 20 years of age Who may not be able to join: - People (or their legal decision-maker) who do not wish to participate in the trial - People who are already taking part in another c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04947657 · Tulane University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) — either the kind that comes and goes (paroxysmal) or the kind that persists over time (persistent) - People who are already scheduled to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04964765 · University Hospital, Basel, Switzerland Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇦🇹 AT🇨🇭 CH

**Who might be able to join this trial:** - People who have undergone cardiac (heart) surgery - People (or their next of kin) who have signed a consent form to take part - People who develop a new irregular heart rhythm called atrial fibrillation (a condition where the upper chambers of the heart beat irregularly) for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04977076 · Zuyderland Medisch Centrum Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇳🇱 NL

**Who might be able to join this trial:** - Adults aged 18 or older who are taking a type of blood-thinning medication called a direct oral anticoagulant (DOAC) and are scheduled for a planned heart artery imaging procedure (coronary angiogram) or a procedure to open blocked heart arteries (such as a stent placement) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04997824 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2031
🇰🇷 KR

Who might be able to join this trial: - People whose left atrium (one of the heart's chambers) measures less than 55 mm in size - People whose irregular heart rhythm (atrial fibrillation) has come back even while taking heart rhythm medications, or who cannot tolerate those medications - People for whom a doctor has de...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05009797 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2031
🇫🇷 FR

"Who might be able to join this trial: - Adults who are scheduled to have a catheter ablation procedure to treat an irregular heartbeat condition called atrial fibrillation - People who are able to understand and agree to participate in the trial on their own behalf Who may not be able to join: - Children and young pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05029570 · Daniel Rodríguez Muñoz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2030
🇪🇸 ES

Who might be able to join this trial: - You have a permanent form of irregular heartbeat called atrial fibrillation. - You have been admitted to hospital at least once in the past 12 months because of heart failure. - Your heart's pumping strength is above 40% (as measured by a heart scan). - Your resting heart rate is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05048004 · Charite University, Berlin, Germany Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇩🇪 DE

"Who might be able to join this trial: - People who have atrial fibrillation (an irregular heartbeat condition) and are scheduled to have their first-ever catheter ablation procedure (a treatment that uses energy to correct abnormal heart rhythms) at Charité-Campus Benjamin Franklin hospital - People who are 18 years o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05062239 · Lars Peter Riber Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇩🇰 DK

Who might be able to join this trial: - People who are scheduled for a planned (non-emergency) heart valve replacement surgery using a biological (tissue-based) valve, with no other heart procedures being done at the same time - People who have a normal, regular heart rhythm and are not taking any heart rhythm medicati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05080712 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2027
🇸🇪 SE

Who might be able to join this trial: - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition). - People whose atrial fibrillation diagnosis was made within the last year before joining the trial. Who may not be able to join: - People who have had atrial fibrillation for longer than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05106270 · Shanghai 10th People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 November 2023
🇨🇳 CN

**Who might be able to join this trial:** - People who have had atrial fibrillation (an irregular heartbeat) recorded on a heart tracing test lasting longer than 30 seconds, within the past 6 months. - People whose situation makes them suitable for a procedure to close off a small pouch in the heart called the left at...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05111015 · AtriCure, Inc. Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 1 January 2040
🇦🇹 AT🇨🇦 CA🇺🇸 US

**Who might be able to join this trial:** - You have been scheduled by your doctor to have, or have already had, a heart ablation procedure (a treatment that uses energy to correct abnormal heart rhythms) - You are willing to sign a consent form agreeing to take part in the study - You are 18 years of age or older, or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05115214 · Medtronic Cardiac Ablation Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2027
🇨🇿 CZ

**Who might be able to join this trial:** - You have been diagnosed with symptomatic paroxysmal (comes and goes) or persistent atrial fibrillation (irregular heartbeat), confirmed by a doctor's notes and at least two recorded episodes in the past 12 months. - You have tried at least one heart rhythm medication but it e...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05116384 · University of Rochester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged over 18 years - People who have persistent atrial fibrillation (an irregular heart rhythm lasting more than 7 days but less than 1 year) that is causing symptoms, and whose condition meets current guidelines for a specific heart procedure called pulmonary vein is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05136131 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been diagnosed with persistent atrial fibrillation (an ongoing irregular heart rhythm condition) - People whose level of symptoms related to their atrial fibrillation is not yet fully known or measured **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05144503 · Medtronic Cardiac Ablation Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2027
🇱🇹 LT

Who might be able to join this trial: - People who have been diagnosed with symptomatic atrial fibrillation (an irregular heartbeat) that comes and goes or is persistent, with at least two recorded episodes in the past 12 months confirmed by heart tracing tests. - People for whom at least one heart rhythm medication ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05147792 · Conformal Medical, Inc Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇨🇿 CZ🇫🇷 FR🇬🇪 GE🇩🇪 DE🇺🇸 US Uzbekistan

Who might be able to join this trial: - Adults aged 18 or older who are male or not currently pregnant - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF), whether it comes and goes, has lasted a long time, or is permanent - People whose doctors have calculated their stro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05164107 · Kardium Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇿 CZ

**Who might be able to join this trial:** - People who are scheduled to have a catheter ablation procedure for atrial fibrillation (AF), with a confirmed AF diagnosis within the past 12 months before enrolling. - People who have had one previous ablation procedure to isolate the pulmonary veins (using cryo, radiofreque...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05174052 · University of Oklahoma Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 April 2027
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with diabetes mellitus (DM) - You experience episodes of an irregular heartbeat that come and go (known as paroxysmal atrial fibrillation, or AF) **Who may not be able to join:** - You have Type 1 diabetes - You have symptoms of low blood pressure, or...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05227053 · Medtronic Cardiac Ablation Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) that is causing symptoms - You are 18 years of age or older (or meet the minimum age required in your country) - Your doctor is planning to treat your condition usi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05238610 · Asan Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who are older than 60 years of age - People who have been diagnosed with a type of stroke called ESUS (a stroke where no clear cause was found) within the last 180 days (about 6 months) from when the stroke started - People in whom a hole in the heart called a PFO (pat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05264831 · Elsan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2025
🇫🇷 FR

**Who might be able to join this trial:** - You have persistent atrial fibrillation (an irregular heartbeat that has continued without stopping for at least 7 days), confirmed by your cardiologist - Your atrial fibrillation causes symptoms and has not been controlled by at least one heart rhythm medication, including...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05266144 · Peking Union Medical College Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with non-valvular atrial fibrillation (an irregular heartbeat not caused by a heart valve problem), including types that come and go or are ongoing - People between 18 and 80 years old - People whose left atrium (one of the heart's chambers) measure...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05300997 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇨🇳 CN

"Who might be able to join this trial: - Adults aged 18 or older. - People who show signs of a possible stroke, identified by standard stroke screening tools used by emergency teams. - People whose symptoms started within the last 24 hours. - People who are able to give informed consent to take part. - People who are n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05311137 · Shanghai 10th People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2024
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - People who are able to make their own decisions, understand what the trial involves, and sign a consent form Who may not be able to join: - There are no stated exclusion criteria — the t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05326828 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 May 2026
🇨🇭 CH

**Who might be able to join this trial:** *ICM group (with implantable cardiac monitor):* - Adults aged 18 or older - Able and willing to provide written consent to participate - Diagnosed with a type 1 heart attack (as defined by current international medical guidelines) - Coronary arteries that are not significantly...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05332457 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇹🇼 TW

**Who might be able to join this trial:** - People who are older than 20 years of age. - People who have a stable, ongoing irregular heartbeat (called persistent atrial fibrillation) and have been taking a type of heart-rate-slowing medication called a beta-blocker, at the same dose, for at least 3 months. - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05333666 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇹🇼 TW

**Who might be able to join this trial:** - People who are older than 20 years of age. - People who are currently taking a NOAC (a type of blood-thinning medication, also called a Non-Vitamin K Antagonist Oral Anticoagulant). **Who may not be able to join:** - People who are unable to provide at least one blood sample...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05353140 · Xijing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 September 2028
🇨🇳 CN

**Who might be able to join this trial:** - People who have had a successful procedure to open blocked heart arteries (called PCI) due to chest pain caused by reduced blood flow (unstable angina or stable coronary artery disease) - People who have a type of irregular heartbeat called atrial fibrillation that is not ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05357690 · Mayo Clinic Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are scheduled for cardiac surgery at the Mayo Clinic in Rochester, Minnesota. - People who are scheduled to have mitral or aortic valve surgery, with or without also having coronary artery bypass grafting (a procedure to improve blood flow to the heart). **Who may...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05366361 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been referred for an ablation procedure or Maze surgery at Stanford Medicine for persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days or requires a medical procedure to stop) - People whose irregular heartbeat has not been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05367037 · Quovadis Associazione Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇮🇹 IT

**Who might be able to join this trial:** - You are 18 years of age or older and able to give your own consent to participate - You have a longer-than-normal delay in the electrical signal between the upper and lower chambers of your heart (a measurement called PR interval greater than 180 ms on a heart tracing) - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05369195 · Silesian Centre for Heart Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇵🇱 PL

**Who might be able to join this trial:** - People aged 18 years or older - People who are able to read, understand, and sign a consent form agreeing to take part - People who have been diagnosed with atrial fibrillation (an irregular heartbeat), whether it is permanent, long-lasting, or comes and goes - People whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05371405 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are having an ablation procedure at Stanford for atrial fibrillation (AF) that either stops on its own within 7 days, or requires a medical procedure to stop it. - You have already tried at least one medication to control your heart rhythm that either did not work or caus...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05378035 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 September 2027
Hong Kong

**Who might be able to join this trial:** - People of Chinese background who have a type of irregular heartbeat (called non-valvular atrial fibrillation) and have been taking one of these blood-thinning medicines for 6 months or more: apixaban, dabigatran, edoxaban, or rivaroxaban. - People between 18 and 80 years old....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05378308 · Henan Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing (ECG), heart monitor, or implanted device, OR you have been diagnosed with a blood clot condition (either a new or returning clot in a vein) - You have been taking blood-th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05411614 · St. George's Hospital, London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇬🇧 GB

**Who might be able to join this trial:** - Adults aged 18 or older - People who have a type of irregular heartbeat called atrial fibrillation (AF) that is either persistent (lasting a long time without stopping on its own) or long-standing persistent (lasting more than a year) - People whose left atrium (one of the he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05427435 · University Hospital, Bordeaux Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 May 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who have been assessed as suitable candidates for a catheter ablation procedure for atrial fibrillation (AF), including those with a history of symptomatic persistent AF, or those having a repeat procedure for persistent or paroxysmal AF under certain conditions (conf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05432024 · R&D Cardiologie Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇳🇱 NL

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (either episodes that come and go, or a more ongoing form), meeting specific diagnosis guidelines set by a major European heart organisation in 2020 - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05442970 · Universitätsklinikum Hamburg-Eppendorf Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇩🇪 DE

Who might be able to join this trial: - You are between 18 and 85 years old - You are able and willing to sign a consent form agreeing to take part in the study Who may not be able to join: - You do not have a good enough understanding of the German language to read the study documents and complete a computer-assisted...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05452356 · London Health Sciences Centre Research Institute OR Lawson Research In... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇨🇦 CA

Who might be able to join this trial: - People who have any type of heart or blood vessel condition. - People who are able to give their consent to take part in the study. - People who are proficient in English. - People who have access to a device (such as a smartphone or tablet) that can run a mobile app. - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05504356 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People who own a smartphone (iPhone or Android) with an active phone number, and who are willing to download the Eureka Research Platform app - People who have an email address that can be used to access a web portal on any internet-connected devic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05508256 · Charite University, Berlin, Germany Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2026
🇩🇪 DE

**Who might be able to join this trial:** - Adults aged 18 or older - People who have given written consent to participate - People with heart failure that causes symptoms, rated as moderate (a classification doctors use called NYHA Class II or III) - People who have a type of irregular heartbeat called atrial fibrill...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05508932 · University Hospital of Ferrara Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2032
🇮🇹 IT

Who might be able to join this trial: - You have a condition called Beta-thalassemia that requires regular blood transfusions to manage - You are currently being monitored and receiving care at the Cardiology Unit of the University Hospital of Ferrara - You have had a heart rhythm test (ECG/electrocardiogram) performed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05539040 · Imperial College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 February 2026
🇬🇧 GB

**Who might be able to join this trial:** - You are between 18 and 85 years old (male or female) - You have been diagnosed with paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) and are experiencing symptoms from it - Your doctor has determined that a catheter ablation procedure (a treatment f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05557526 · Evangelical Hospital Düsseldorf Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇩🇪 DE

Who might be able to join this trial: - You have atrial fibrillation (an irregular heartbeat) that is causing symptoms such as palpitations, shortness of breath, or fatigue - Your doctor has recommended a procedure called pulmonary vein isolation (a treatment to correct the irregular heartbeat) - You are able to unders...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05565209 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 September 2026
🇫🇷 FR

Who might be able to join this trial: - Any patient who has been recommended by their doctor to have a device implanted to close a small pouch in the heart called the left atrial appendage, regardless of the reason for the recommendation or whether the procedure ends up being successful Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05565781 · Hospital Universitari Vall d'Hebron Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇪🇸 ES

**Who might be able to join this trial:** - People aged 55 years or older - People who have been diagnosed with a stroke where the cause could not be found, after completing a standard set of tests including brain scans, blood vessel scans, a 24-hour heart rhythm test, and a heart ultrasound - People who have had a str...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05573633 · Centre Hospitalier Universitaire, Amiens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 October 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who were admitted to Amiens University Hospital for heart surgery that involved being connected to a heart-lung bypass machine (known as "on-pump" cardiac surgery) - People whose on-pump heart surgery took place within the last 96 hours (4 da...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05598632 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older, of any gender - People who have a documented history of atrial fibrillation (an irregular heartbeat condition) - People who are able to sign and provide written consent to participate Who may not be able to join: - People who have a moder...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05617456 · Giulio Zucchelli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇮🇹 IT

**Who might be able to join this trial:** - People who have been assessed by their doctor as needing an ablation procedure for atrial fibrillation, in line with current medical guidelines. - People who are willing and able to give informed consent and attend all required appointments at an approved study centre. - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05633303 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 October 2027
🇬🇧 GB

Who might be able to join this trial: - People who are scheduled to have a catheter ablation procedure (a heart procedure using thin, flexible tubes) for a type of irregular heartbeat called persistent atrial fibrillation, where the irregular heartbeat has been present for less than 24 months and no previous ablation p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05638841 · Peking University Third Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - You must be older than 18 years of age. - You must have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing test (ECG or Holter monitor). Who may not be able to join: - People who have blood diseases, autoimmune diseases, or cancer. - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05643235 · Northwell Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are over 18 years of age - People who are willing to sign and date a consent form - People who are willing to have their heart monitored remotely - People who are about to start a type of cancer treatment called a BTK inhibitor for an approved condition (such as ce...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05664308 · Nantes University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 March 2026
🇫🇷 FR

Who might be able to join this trial: - Adults (18 years or older) who are scheduled to have open heart surgery using standard surgical methods. - People who develop a new irregular heartbeat (called atrial fibrillation) after their heart surgery, which was not present before the operation. - People who agree to take p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05712200 · Anthos Therapeutics, Inc. Phase 3 · 35 countries Recruiting
Recruiting Phase 3 Est. completion 30 December 2027
🇦🇷 AR🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇱 CL🇨🇳 CN🇨🇴 CO🇭🇷 HR +27 more

**Who might be able to join this trial:** - People who are able to understand the trial and have agreed in writing to take part - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) or atrial flutter, confirmed by a heart tracing (ECG) or monitor recording - People aged 65–74 with a stroke...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05717725 · Charles University, Czech Republic Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 September 2025
🇨🇿 CZ

**Who might be able to join this trial:** - People who are older than 18 years of age - People who have been diagnosed with paroxysmal atrial fibrillation (AF that comes and goes) or persistent atrial fibrillation (AF that lasts but has not been continuous for more than a year) - People whose AF quality-of-life score...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05723926 · Javelin Medical Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 20 December 2028
🇨🇦 CA🇺🇸 US

**Who might be able to join this trial:** - You have a confirmed diagnosis of atrial fibrillation (an irregular heartbeat condition) - You have had an ischemic stroke (a stroke caused by a blocked blood vessel, not bleeding) — including cases where stroke symptoms went away within 24 hours but a brain scan showed evid...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05724121 · National Heart, Lung, and Blood Institute (NHLBI) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 April 2027
🇺🇸 US

Who might be able to join this trial: - People who are currently receiving, or are planning to receive, a type of cancer medication called a BTK inhibitor or venetoclax - People who are 18 years of age or older, of any gender - People who are willing to follow all study procedures and are available for the full duratio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05773768 · University Medical Center Groningen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇳🇱 NL

Who might be able to join this trial: - People who have been newly diagnosed with atrial fibrillation (an irregular heart rhythm), whether it comes and goes, has lasted a while, or is ongoing - People who are 65 years of age or older - People who are willing and able to take part and attend scheduled follow-up appointm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05776797 · University Hospital Ostrava Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇿 CZ

**Who might be able to join this trial:** - You have a heart device called a cardiac resynchronisation therapy (CRT) pacemaker or defibrillator, and have had it for more than 6 months - You have been diagnosed with an irregular heart rhythm called atrial fibrillation (AF), which is either permanent or keeps coming back...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05777551 · Clinica Mediterranea Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇫🇷 FR🇮🇹 IT🇬🇧 GB

Who might be able to join this trial: - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that comes and goes or is ongoing, and who have agreed to take part by signing a consent form - People who are currently taking blood-thinning medication (anticoagulants) in tablet o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05790707 · Poitiers University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇫🇷 FR

Who might be able to join this trial: - People aged between 60 and 80 years old - People who have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) - People whose doctor has recommended treatment to restore a normal heart rhythm - People who have scored between...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05794386 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 years or older who have ongoing, symptomatic atrial fibrillation (an irregular heart rhythm that hasn't stopped) and are scheduled for a catheter ablation procedure because medication has not controlled their condition - People who have a moderate amount of sc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05794464 · University Hospital Ostrava Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇨🇿 CZ

Who might be able to join this trial: - People who have atrial fibrillation (an irregular heartbeat), either the type that comes and goes (paroxysmal) or the type that has lasted a while but can still be treated (persistent) - People whose doctor has recommended a procedure to reset their heart rhythm, either using a c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05795842 · Emory University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 55 years of age or older - You have recently been discharged from hospital after having an ischemic stroke (a stroke caused by a blood clot) where doctors were not able to find the exact cause - You are receiving follow-up care at the Emory Stroke Clinic - Your doctor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05829317 · Dr. Stephanie Sibley Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2028
🇨🇦 CA

Who might be able to join this trial: - People aged 18 or older - People who have been admitted to an intensive care unit (ICU) and are receiving breathing support through a mask or high-flow oxygen, or are on a breathing machine, where that support is expected to last more than 24 hours due to breathing difficulties -...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05841056 · Population Health Research Institute Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 August 2028
🇨🇦 CA

**Who might be able to join this trial:** - People aged 18 or older - People who have had heart surgery — including bypass surgery (CABG), heart valve surgery, replacement of the main artery leaving the heart (ascending aorta), or a combination of these — within the last 14 days - People who developed a new irregular h...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05844501 · Indiana University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 100 years of age (men or women) - People who have been confirmed by an ECG (heart tracing test) to have an irregular heart rhythm called atrial fibrillation (AF) and/or atrial flutter, and who are scheduled for a planned procedure called catheter ablati...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05860894 · Centre Hospitalier Universitaire de Besancon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been newly diagnosed with atrial fibrillation (an irregular heart rhythm) while in the intensive care unit (ICU), confirmed by a heart tracing test or a recorded episode lasting at least 30 seconds - People who are currently in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05890664 · University Hospital, Basel, Switzerland Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 March 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who are over 18 years of age - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) confirmed by a heart tracing (ECG) before their cardioversion procedure - People whose heart was successfully returned to a normal rhythm during cardiover...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05891145 · Yangzhou University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who are between 50 and 70 years old - People with a Body Mass Index (BMI) between 18 and 28 (a measure of body weight relative to height) - People who are scheduled to have a planned (non-emergency) coronary artery bypass graft (CABG) heart surgery at the Yangzhou Institut...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05900414 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) that is not caused by a heart valve problem, within the last 12 months, at any level of stroke risk. - People who are 18 years of age or older. - People who are either not currently taking blood-thin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05903170 · Wellington Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇳🇿 NZ

Who might be able to join this trial: - People who are older than 18 years of age - People who are scheduled for a planned (non-emergency) procedure to restore a normal heart rhythm, either as an outpatient or as a hospital inpatient, for a condition called atrial fibrillation (an irregular heartbeat) - People for whom...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05908955 · Chinese Academy of Medical Sciences, Fuwai Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) that causes symptoms and has not improved with one or more heart rhythm medications. - People who are willing to have a catheter ablation procedure (a procedure to treat the irr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05920824 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇬🇧 GB

Who might be able to join this trial: - You must be willing and able to give your consent to take part in the trial - You must be 18 years old or older - You have been diagnosed with atrial fibrillation (an irregular heartbeat) - You have been told you have moderate or severe disease affecting your heart's mitral valve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05928728 · Herlev and Gentofte Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 14 June 2026
🇩🇰 DK

**Who might be able to join this trial:** - You live in the Capital Region of Denmark - You are over 18 years old - You have been diagnosed with atrial fibrillation (AF) that comes and goes or is ongoing (not permanent) - You have had or are scheduled for a cardioversion procedure (a procedure to reset your heart rhyt...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05955365 · Insel Gruppe AG, University Hospital Bern Phase 4 · 9 countries Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇧🇪 BE🇫🇷 FR🇩🇪 DE🇮🇹 IT🇳🇱 NL🇵🇱 PL🇪🇸 ES🇨🇭 CH +1 more

**Who might be able to join this trial:** - People aged 18 or older - People who have atrial fibrillation or atrial flutter and whose doctor has determined they need to take a type of blood thinner called a direct-acting oral anticoagulant (DOAC) for at least 12 months - People who have had a successful procedure to op...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05961748 · Beijing Tiantan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2032
🇨🇳 CN

Who might be able to join this trial: - People who are older than 18 years of age. - People who have been newly diagnosed with one of the following heart or blood vessel conditions: a heart attack (including certain types classified as acute coronary syndrome), cardiac arrest, atrial fibrillation or atrial flutter (irr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05961865 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇮🇹 IT

**Who might be able to join this trial:** - You have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes, or that is ongoing - You are already scheduled to have a catheter ablation procedure (a treatment for irregular heartbeat) that is approved by European heart guidelines - You are be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05988411 · Vivek Reddy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older - People who are scheduled for a repeat heart rhythm procedure (called AF ablation) for atrial fibrillation — either the type that comes and goes (paroxysmal) or the type that is more continuous (persistent) — where the main recurring abnormal rhythm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05991700 · University of Michigan Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 to 79 years who are patients at the Mitral Valve Clinic/CVC and are scheduled for planned (non-emergency) heart surgery to repair the mitral valve, without a specific heart rhythm procedure called the Cox MAZE procedure - People having mitral valve repair who a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05996159 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇰🇷 KR

**Who might be able to join this trial:** - You have a type of irregular heartbeat called paroxysmal atrial fibrillation (AF that comes and goes) and are scheduled to have a specific heart procedure called pulmonary vein isolation (a procedure to treat this irregular heartbeat) **Who may not be able to join:** - You a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06005233 · Technical University of Munich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇩🇪 DE

Who might be able to join this trial: - People who have had a small heart monitor (called an implantable loop recorder with remote monitoring) surgically placed under their skin to track heart rhythms. - People who have had a stroke within the last six months that doctors could not find a clear cause for, after a full...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06007872 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

Who might be able to join this trial: - People who meet the standard medical guidelines for receiving a commercially available Watchman device (a small implant used to reduce stroke risk in people with a certain type of irregular heartbeat) - People who are not currently enrolled in another active clinical trial Who m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06019845 · Stereotaxis Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇰 DK🇱🇹 LT🇳🇱 NL🇵🇱 PL

**Who might be able to join this trial:** - People who are 18 years of age or older at the time of signing consent - People who have a heart rhythm problem (affecting the upper or lower chambers of the heart) that has been recorded on a heart monitor test within the past 12 months, and for whom an ablation procedure i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06021808 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇨🇳 CN

Who might be able to join this trial: - You are 18 years of age or older. - You have been diagnosed with a long-lasting or ongoing irregular heartbeat (called persistent or long-standing persistent atrial fibrillation), confirmed by your medical records or a heart tracing test (ECG). - Your doctor has calculated your s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06023888 · Taipei Veterans General Hospital, Taiwan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇹🇼 TW

Who might be able to join this trial: - People who have persistent atrial fibrillation (an irregular heartbeat that does not stop on its own) - People whose atrial fibrillation has not responded to medication, or who are unable to tolerate the medication used to treat it Who may not be able to join: - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06026345 · Medtronic Cardiac Ablation Solutions Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇧🇪 BE🇨🇿 CZ🇫🇷 FR🇩🇪 DE🇮🇪 IE🇨🇭 CH🇬🇧 GB

Who might be able to join this trial: - People who are 18 years of age or older (or meet the minimum age required by local rules) - People who are already scheduled to have a procedure using the Affera Platform, which is a commercially available medical device - People who are willing and able to follow the study requi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06053606 · Wroclaw Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇵🇱 PL

Who might be able to join this trial: - People having their first pulmonary vein isolation (PVI) procedure, which is a treatment for an irregular heart rhythm condition - People diagnosed with paroxysmal atrial fibrillation, meaning their irregular heart rhythm comes and goes rather than being constant - People whose h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06054360 · Centre Hospitalier Universitaire, Amiens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 October 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are admitted to Amiens University Hospital for a planned coronary artery bypass graft surgery (a scheduled heart bypass operation) using a heart-lung bypass machine - People whose heart ultrasound (echocardiogram) images ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06055751 · Kansas City Heart Rhythm Research Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - People over 18 years of age who have severe narrowing of the heart's aortic valve (aortic stenosis) and have had a procedure called TAVI (a non-surgical way to replace the aortic valve) - People who developed a new or worsened electrical conduction problem in their heart, det...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06061120 · RWTH Aachen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2024
🇩🇪 DE

Who might be able to join this trial: - People who are scheduled to have an ablation procedure for a heart rhythm condition known as supraventricular tachycardia (this includes atrial fibrillation, typical atrial flutter, AV nodal reentry tachycardia, or an accessory pathway condition) - People who are 18 years of age...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06065124 · University Medical Center Groningen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇳🇱 NL

**Who might be able to join this trial:** - You have been diagnosed with heart failure based on European heart specialist guidelines - Your heart is pumping at least 40% of its normal capacity (your doctor can check this) - You have scored a certain level on a specialist heart failure assessment called the HFA-PEFF sc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06078735 · Kansas City Heart Rhythm Research Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are able and willing to give their consent to participate - People who are already scheduled for a planned medical procedure that involves inserting a needle into a vein (such as a heart procedure for atrial fibrillation),...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06090591 · University Hospital Dubrava Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2033
🇭🇷 HR

Who might be able to join this trial: - People who have had a cardiac implantable electronic device (a pacemaker or similar heart device) implanted - People who have been diagnosed with a blood clot in a vein or lung (venous thromboembolism) - People who have experienced a heart attack or severe chest pain caused by re...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06096246 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 July 2027
🇬🇧 GB

Who might be able to join this trial: - People who are able to give their consent to participate in the study - People aged between 18 and 85 years old - People who have had an irregular heart rhythm (atrial fibrillation) that has lasted more than 7 days but less than 2 years in total, as recorded in their medical note...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06099106 · Endomatic Ltd. Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇬🇪 GE🇱🇹 LT🇵🇱 PL Uzbekistan

**Who might be able to join this trial:** - You have a score of 2 or higher on a standard stroke risk calculator used for people with atrial fibrillation (called the CHA2DS2-VASc score) - You are not a good candidate for long-term blood thinning medication, or there is a good reason to look for a non-medication alterna...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06099730 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes or is persistent, with at least one episode confirmed by a heart monitor or ECG recording within the past 24 months. - You are between 18 and 80 years old. - You are willing and able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06108414 · China National Center for Cardiovascular Diseases Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 70 years or older - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm), confirmed by a heart tracing test (ECG or Holter monitor) showing an episode lasting at least 30 seconds within the past year - People whose atrial fibrillation-re...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06124612 · East and North Hertfordshire NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 17 September 2026
🇬🇧 GB

Who might be able to join this trial: - You are 18 years old or older - You are already enrolled in a related study called OCEANIC-AF - You are willing and able to read and understand the patient information sheet and sign a consent form - You agree to have blood samples taken as part of the study Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06125925 · The First Affiliated Hospital with Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have atrial fibrillation (an irregular heartbeat) that comes and goes or is ongoing, and it causes symptoms - Your doctor has calculated a stroke risk score (called CHA₂DS₂-VASc) of 2 or higher - You have been diagnosed with a type of heart failure where the heart pumps n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06145906 · Henan Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are having radiofrequency catheter ablation (a procedure to treat an irregular heartbeat) for the very first time - You have been diagnosed with atrial fibrillation (an irregular heart rhythm) confirmed by an ECG (a heart tracing test) **Who may not be able to join:** -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06157437 · Hangzhou Dinova EP Technology Co., Ltd Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have had at least one confirmed episode of a specific type of irregular heart rhythm called atrial flutter, recorded by a heart tracing (ECG or Holter monitor) in the 180 days before joining the trial — recordings from other ho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06164808 · HelpWear Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

Who might be able to join this trial: - People who are at least 22 years old at the time of signing the consent form - People who have been advised by their doctor to have a Holter monitor test (a test that records heart activity over time) - People who are able to wear a smartwatch-style device called the HeartWatch o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06165510 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇬🇧 GB

**Who might be able to join this trial:** - People who are older than 18 years and younger than 80 years - People who have had persistent atrial fibrillation (an irregular heart rhythm) lasting more than 1 year - People whose left atrium (a chamber of the heart) measures less than 6cm in size - People who are able to s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06176131 · University Hospital Bispebjerg and Frederiksberg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇩🇰 DK

"Who might be able to join this trial: - People admitted to hospital with a sudden worsening of heart failure who also had at least one previous hospital admission for worsening heart failure in the three months before this current admission. - People admitted to hospital with a sudden worsening of heart failure who al...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06184633 · Rijnstate Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2026
🇳🇱 NL

**Who might be able to join this trial:** - People who have been recently diagnosed with persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) that is causing symptoms, diagnosed no more than 6 months before joining the trial - People aged 18 or older - People with a body mass index (B...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06187155 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older who have a medical reason to take blood-thinning medication called a VKA (vitamin K antagonist, such as warfarin) long-term, and who have already been taking it for more than 6 months. Who may not be able to join: - People who do not wish to take part in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06187311 · Korea University Anam Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2026
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older at the time of screening - People whose atrial fibrillation (an irregular heart rhythm) has been confirmed by a heart tracing (ECG) during screening and at the baseline visit - People who have a stroke risk score (called CHA2DS2-VASc) of 1 or mo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06199180 · University Medical Center Groningen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇳🇱 NL

Who might be able to join this trial: - People who have had one previous pulmonary vein isolation (a specific heart procedure for atrial fibrillation) using one of three methods: cryoballoon, radiofrequency ablation, or pulsed field ablation - People whose first pulmonary vein isolation procedure took place less than 5...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06207383 · University Hospital, Geneva Not Applicable · 14 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇦🇹 AT🇧🇪 BE🇧🇬 BG🇨🇿 CZ🇫🇮 FI🇫🇷 FR🇩🇪 DE🇭🇺 HU +6 more

Who might be able to join this trial: - People who have persistent atrial fibrillation (an irregular heart rhythm that does not stop on its own) along with heart failure symptoms that have not improved enough with medication, and who have been assessed as suitable for a heart procedure called AF ablation, with no more...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06212791 · Virginia Commonwealth University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇺🇸 US

Who might be able to join this trial: - People aged 18 years or older - People who have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes on its own) - People whose heart is pumping at a normal or near-normal level (a heart pumping function measurement of 50% or above...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06216769 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇰🇷 KR

Who might be able to join this trial: - People who are scheduled to have a catheter ablation procedure for atrial fibrillation (an irregular heartbeat) because medication has not worked well enough to control it. - People with a stroke risk score (called CHA2DS2-VASc, not counting gender) of between 1 and 4. - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06220006 · Hospital Clinic of Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇪🇸 ES

Who might be able to join this trial: - People who are scheduled to have their first-ever catheter ablation procedure for atrial fibrillation (an irregular heart rhythm condition) Who may not be able to join: - People under 18 years of age - People with a long-standing persistent form of atrial fibrillation (where the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06245187 · American Heart Association Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2040
🇺🇸 US

Who might be able to join this trial: - You are currently admitted to a hospital with a heart rhythm condition called atrial fibrillation or atrial flutter that is not caused by a heart valve problem Who may not be able to join: - You do not have atrial fibrillation or atrial flutter that is unrelated to a heart valve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06249269 · Ratika Parkash Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - You have atrial fibrillation (an irregular heartbeat) that causes noticeable symptoms affecting your daily life - Your atrial fibrillation comes and goes, or has been ongoing, and medications to control your heart rate have not been enough - You want to have a procedure call...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06249347 · Second Affiliated Hospital of Wenzhou Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who are older than 18 years of age - People who have persistent atrial fibrillation (an irregular heart rhythm that has lasted more than 7 days) - People whose heart condition and health history place them at a moderate-to-high risk of stroke, as measured by a standard med...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06253000 · Bakulev Scientific Center of Cardiovascular Surgery Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇷🇺 RU

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have atrial fibrillation (an irregular heart rhythm) that has not responded to medication designed to control heart rhythm - People who have a persistent or long-standing persistent form of atrial fibrillation (meaning the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06263608 · University Hospital, Antwerp Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇧🇪 BE

Who might be able to join this trial: - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) — either the kind that comes and goes (paroxysmal) or the kind that lasts longer (persistent) — confirmed by a heart tracing test (ECG) - People who experience noticeable symptoms from their atrial f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06271707 · University of Minnesota Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 15 April 2027
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 85 who are scheduled to have surgery to remove part or all of the oesophagus (food pipe), or part or all of a lung. Who may not be able to join: - People for whom regional anaesthesia (numbing a specific area of the body with nerve-blocking injections) is not m...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06279793 · GCP-Service International West GmbH Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 March 2030
🇩🇪 DE

**Who might be able to join this trial:** - You must be willing and able to sign a consent form before the study begins - You must be 18 years old or older - You must be scheduled for planned (non-emergency) heart surgery using a heart-lung bypass machine, and your surgery must be one of the following types: heart valv...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06299514 · Habib Khan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇦 CA

**Who might be able to join this trial:** - People who have permanent or persistent atrial fibrillation (an irregular heart rhythm that does not go back to normal on its own) - People who have moderate to severe heart failure symptoms (classified as NYHA Class II to IVa, meaning symptoms range from slight limitations...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06315192 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2027
🇸🇪 SE

**Who might be able to join this trial:** - You are 50 years of age or older - You are mostly independent in daily life with little to no disability (confirm with trial site) - You have recently (within the last 2 weeks) had a mini-stroke (TIA) AND either have a high risk score, an irregular heart rhythm called atrial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06324201 · Heart Rhythm Clinical and Research Solutions, LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇺🇸 US

Who might be able to join this trial: - People who have atrial fibrillation (an irregular heartbeat) that comes and goes on its own within 7 days, has not responded to medication, and whose doctor considers them a suitable candidate for an ablation procedure - People aged 18 years or older - People who are able and wil...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06324682 · University Hospital of Ferrara Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2033
🇮🇹 IT

**Who might be able to join this trial:** - People who have a medical need for cardiac stimulation (a device to help regulate or support the heart's rhythm) - People who have already had a cardiac stimulation device implanted **Who may not be able to join:** - People under 18 years of age - People who are currently pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06355063 · Pulse Biosciences, Inc. Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇦🇹 AT🇳🇱 NL🇵🇱 PL

**Who might be able to join this trial:** - People between 18 and 85 years of age - People who are willing and able to give informed consent and attend all required follow-up visits - People who have a confirmed diagnosis of atrial fibrillation (an irregular heart rhythm) within the past year, supported by a heart tra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06358391 · Starmed Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 August 2025
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have a confirmed diagnosis (shown in their medical records) of one of the following heart conditions: - **Atrial fibrillation** (any type — paroxysmal, persistent, long-standing persistent, or permanent), confirmed by an ECG recording l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06363604 · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇳 CN

Who might be able to join this trial: - You are between 18 and 85 years old - You have persistent atrial fibrillation (an irregular heartbeat lasting at least 1 week) that is causing symptoms, is not caused by a heart valve problem, and has not been controlled by at least one heart rhythm medication - You are planning...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06376916 · Wake Forest University Health Sciences Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 years or older - People who are able to give informed consent (agree to participate after being told what the study involves) - People whose main diagnosis is a fast, irregular heartbeat called atrial fibrillation or atrial flutter, with a heart rate of 120 bea...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06383975 · Sebastien Knecht Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇧🇪 BE

Who might be able to join this trial: - People who have persistent atrial fibrillation (an irregular heart rhythm lasting 7 days or more) that is still causing symptoms after already having a procedure called pulmonary vein isolation (PVI) to treat it Who may not be able to join: - People whose atrial fibrillation has...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06392932 · Cedars-Sinai Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇺🇸 US

Who might be able to join this trial: - People who are able to sign and date a consent form agreeing to take part in the study - People who are willing to follow all study procedures and are available for the full duration of the study - People who are 18 years of age or older, of any gender - People who have been diag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06393920 · Medtronic Cardiac Ablation Solutions Not Applicable · 12 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇨🇦 CA🇨🇳 CN🇭🇷 HR🇫🇷 FR🇩🇪 DE🇬🇷 GR🇮🇹 IT🇳🇱 NL +4 more

Who might be able to join this trial: - People who are 18 years of age or older, or meet the minimum age required by local regulations. - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition). - People whose doctor is planning to perform a procedure using a specific commercially ava...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06396299 · Mahidol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇹🇭 TH

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing test (ECG), either in a clinic or through a wearable heart monitor. Who may not be able to join: - People who have had a stroke caused by a blood clot...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06399666 · Vrinnevi Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇸🇪 SE

Who might be able to join this trial: - People who have been diagnosed with persistent atrial fibrillation (a type of irregular heartbeat that does not stop on its own) - People who are over 18 years of age Who may not be able to join: - People who have an autoimmune disease (where the immune system mistakenly attacks...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06401616 · Odense University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2028
🇩🇰 DK

Who might be able to join this trial: - People who are older than 18 years of age - People who have previously had some type of heart surgery that included a procedure to close off a small pouch in the heart called the left atrial appendage (this includes several different surgical techniques or devices, such as the At...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06402617 · Imperial College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇬🇧 GB

**Who might be able to join this trial:** - You have been diagnosed with persistent atrial fibrillation (an ongoing irregular heartbeat) and your doctor has recommended a procedure called catheter ablation to treat it. - Your doctor has assessed you as a suitable candidate for catheter ablation. - You are willing and a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06436924 · Heart Rhythm Clinical and Research Solutions, LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are able and willing to attend all study visits and check-ins for the full duration of the study - People who a doctor (the study investigator) has determined are medically appropriate to receive a left atrial appendage closure...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06445439 · Medstar Health Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 90 years old - People who have been diagnosed with persistent or permanent atrial fibrillation (an irregular heart rhythm that doesn't go away on its own) - People who received a CRT device (a type of heart pacemaker) or a specialised pacing device between 3 mon...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06455644 · First Affiliated Hospital of Shantou University Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 years or older - People with a type of irregular heartbeat called atrial fibrillation (not caused by a heart valve problem) who are already scheduled to have two specific heart procedures: a procedure to correct the irregular heartbeat (ablation) and a procedure to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06465459 · French Cardiology Society Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇫🇷 FR

**Who might be able to join this trial:** - You need to be recommended for a specific heart procedure (called a left atrial exclusion) using a device called LAMBRE, as advised by French health authorities - You must be 18 years old or older - You must have been told about the study and agreed to take part **Who may no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06475547 · Odense University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 or older. - People who have given their informed consent to participate in the trial. Who may not be able to join: - People who are not able to make their own decisions or give consent (confirm with trial site). - People who are in generally poor health at the tim...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06499857 · University of Chicago Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 75 years old - People with a body mass index (BMI) of 30 or higher (a measure of body weight relative to height) - People who have a type of irregular heartbeat called atrial fibrillation (AF) — either the kind that comes and goes (paroxysmal) or t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06500988 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older at the time of signing consent - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) that either comes and goes in episodes lasting less than 7 days, or has been ongoing for 7 days or longer - People with a B...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06510556 · Boston Scientific Corporation Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 15 February 2027
🇧🇪 BE🇭🇷 HR🇨🇿 CZ🇮🇹 IT

**Who might be able to join this trial:** - Adults aged 18 or older (or older if required by local laws in the country where the trial is taking place) - People who have been diagnosed with symptomatic atrial fibrillation (an irregular heart rhythm) that is either persistent (ongoing) or paroxysmal (comes and goes), c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06516822 · The First Affiliated Hospital with Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇳 CN

Who might be able to join this trial: - People who have atrial fibrillation (an irregular heart rhythm) that has lasted continuously for between 1 and 3 years - People whose atrial fibrillation causes symptoms and has not responded to at least one medication designed to control heart rhythm - People between 18 and 75 y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06523738 · The Second Affiliated Hospital of Chongqing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm that continues for a long period) within the past 6 months - People whose left atrial diameter (a measurement of one of the heart's chambers) was between 40mm and 50mm before entering th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06528262 · Yonsei University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 May 2027
🇰🇷 KR

**Who might be able to join this trial:** - Adults between the ages of 19 and under 85 - People who are willing to give their consent to take part and are able to attend follow-up appointments during the study - People who have both atrial fibrillation (an irregular heartbeat) and heart failure, and who have either had...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06529978 · CoreMap Inc. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇿 CZ🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with persistent or long-standing persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) — (confirm with trial site which phase applies to you) - You have persistent atrial fibrillation and have never had a catheter abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06542263 · Second Affiliated Hospital of Soochow University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with both atrial fibrillation (an irregular heartbeat) and moderate to severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) - You are 18 years old or older - You are willing to take part in the study and agree to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06548269 · Jinan Central Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇨🇳 CN

Who might be able to join this trial: - People who are older than 18 years of age - People who have had an acute (sudden-onset) stroke caused by a blood clot, with the stroke occurring within the last 14 days - People who have been diagnosed with a type of irregular heart rhythm called atrial fibrillation (AF) that is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06552845 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 or older who are willing to take part and are able to sign a consent form - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) and whose doctor has recommended a procedure called catheter ablation to treat it Who may not be able to jo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06556667 · Ottawa Heart Institute Research Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇨🇦 CA

Who might be able to join this trial: - Adults aged 18 years or older. - People who have been diagnosed with persistent atrial fibrillation (an ongoing irregular heartbeat). - People who have an elective cardioversion (a planned procedure to restore a normal heart rhythm) scheduled at the University of Ottawa Heart Ins...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06556732 · Assiut University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 13 August 2024
🇪🇬 EG

Who might be able to join this trial: - You have atrial fibrillation (an irregular heartbeat) that is **not** caused by a heart valve problem, and your heart has been successfully returned to a normal rhythm — whether by medication, an electric shock treatment, or on its own. Who may not be able to join: - You have rh...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06557616 · Medinice S.A. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇵🇱 PL

**Who might be able to join this trial:** - People who have given written agreement to take part in the study. - People aged 18 or older. - People who have been assessed as needing mitral valve surgery (either repair or replacement), with or without a procedure to close a small pouch in the heart called the left atria...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06557876 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 September 2026
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) and whose doctor has recommended a procedure called catheter ablation, according to specific medical guidelines - People who have h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06560047 · Aalborg University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2029
🇩🇰 DK

**Who might be able to join this trial:** - You have been diagnosed with heart failure where the heart pumps less effectively than normal (called "reduced ejection fraction"), and your heart's pumping strength has been measured at below 50% at some point in the last 12 months - You have been diagnosed with an irregula...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06578793 · Second Xiangya Hospital of Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 80 years - People with symptomatic, persistent atrial fibrillation (an irregular heartbeat lasting more than 7 days without returning to normal on its own) that has been present for at least 6 months, with at least two episodes in the past 6 months...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06584266 · University in Zielona Góra Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇿 CZ🇵🇱 PL

**Who might be able to join this trial:** - People who have atrial fibrillation (an irregular heartbeat condition) or atrial flutter (a related heart rhythm problem) and are already scheduled to have a procedure called a transoesophageal echocardiogram (a scan of the heart done through the throat) to check whether they...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06589700 · Luciano A. Sposato Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇨🇦 CA

Who might be able to join this trial: - Adults who have had an acute ischemic stroke (a stroke caused by a blood clot) affecting any part of the brain, whether or not the cause is known - People who have a type of irregular heart rhythm called paroxysmal atrial fibrillation (AF), meaning it comes and goes rather than b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06598280 · University of Luebeck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇪 DE

Who might be able to join this trial: - People aged 18 years or older - People who are scheduled for a planned (non-emergency) catheter ablation procedure for atrial fibrillation, using specific-sized access tubes (6 to 14 Fr inner diameter) inserted into one or two veins in the groin area, regardless of the type of en...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06615596 · China National Center for Cardiovascular Diseases Early Phase 1 · 2 countries Recruiting
Recruiting Early Phase 1 Est. completion 1 January 2029
🇨🇳 CN🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older (but not older than 85) - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition), whether it comes and goes, has lasted a while, or has been ongoing for a long time - People whose heart was successfu...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06620757 · Fundación EPIC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇪🇸 ES

Who might be able to join this trial: - Adults aged 18 years or older. - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that is not caused by a problem with the heart's mitral valve or a mechanical heart valve. - People whose stroke risk score (called CHA₂DS₂-VASc) is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06630936 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇨🇳 CN

**Who might be able to join this trial:** - People between 18 and 80 years of age - People who have been diagnosed with symptomatic paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) with a history of less than 5 years - People who have moderate to severe mitral regurgitation (a leaky heart val...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06647251 · Institut Mutualiste Montsouris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 or older - People who have never previously had an ablation procedure for atrial fibrillation - People diagnosed with paroxysmal atrial fibrillation, meaning their irregular heart rhythm episodes last less than 48 hours - People with early atrial fibrillation, mean...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06647485 · VZW Cardiovascular Research Center Aalst Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇧🇪 BE

Who might be able to join this trial: - People who have paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes), with symptoms, and where the episodes stop on their own or with treatment within 7 days of starting - People aged between 18 and 70 years old - People who are willing and able to give inf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06657404 · Yumei Xue Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older - People who have a type of irregular heart rhythm called atrial fibrillation (AF) that is not caused by heart valve problems and is not the short, occasional type — and who were first diagnosed with AF within the last 5 years - People whose irregular...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06675383 · Vestre Viken Hospital Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇳🇴 NO

Who might be able to join this trial: - You are 18 years old or older - You have had an ischemic stroke (a stroke caused by a blocked blood vessel) - You either have no known history of an irregular heartbeat called atrial fibrillation (AF), or you have been previously diagnosed with an occasional/intermittent form of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06686485 · Boston Scientific Corporation Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇨🇳 CN Hong Kong🇯🇵 JP🇲🇾 MY🇸🇬 SG🇹🇼 TW

Who might be able to join this trial: - People whose doctor has determined they need both the FARAPULSE™ heart rhythm treatment system and the WATCHMAN device to close off a part of the heart called the left atrial appendage, based on standard medical care. - People who are willing and able to give their informed conse...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06696079 · Rahul Raj Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇫🇮 FI🇸🇪 SE

**Who might be able to join this trial:** - Adults aged 18 or older - People who have a chronic subdural hematoma (a blood collection between the brain and its outer covering) on one or both sides of the head that is causing symptoms, and where scans show it is mostly dark or grey in appearance — requiring a specific...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06696170 · Pulse Biosciences, Inc. Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 25 June 2026
🇧🇪 BE🇨🇿 CZ🇮🇹 IT

Who might be able to join this trial: - People aged 18 to 75 years old at the time of joining the trial - People who are willing and able to give informed consent and attend all required visits, tests, and follow-up appointments - People diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06698159 · Hospital Universitario 12 de Octubre Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇮🇹 IT🇪🇸 ES

Who might be able to join this trial: - People who are over 18 years old. - People who have been diagnosed with a type of irregular heart rhythm called atrial fibrillation (either the "comes and goes" type or the ongoing type) within the last 2 years. - People whose doctor has recommended a specific heart procedure tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06699342 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇰🇷 KR

**Who might be able to join this trial:** - People who have been diagnosed with permanent atrial fibrillation (an irregular heart rhythm that does not return to normal) - People aged 65 years or older - People whose atrial fibrillation has not responded to medications meant to control heart rhythm or heart rate, or who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06722196 · Jilin Heart Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 15 January 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are scheduled for planned (non-emergency) heart surgery through a full chest opening (sternotomy) - Your surgery is for one or more of the following conditions: blocked heart arteries, aortic valve problems, mitral valve problems, tricuspid valve problems, or disease of t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06728826 · Changhai Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 years or older - People who need surgery on the upper part of the main blood vessel leaving the heart (the aorta), the heart valves, and/or the arteries that supply blood to the heart - People who are able to give their written agreement to take part in the study...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06730828 · Helios Cardio Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2025
🇺🇸 US

**Who might be able to join this trial:** - People between 20 and 85 years old. - People who are able to give written consent on their own free will and are willing to follow the study procedures. - People who are already scheduled to have open-chest heart surgery through a full cut down the centre of the chest (called...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06735001 · University Hospital, Bordeaux Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2029
🇫🇷 FR

**Who might be able to join this trial:** - People who are 18 years of age or older, of any gender or ethnic background - People who have given their free, informed, and written agreement to take part - People who are covered by, or benefit from, a social security scheme **Who may not be able to join:** - People under...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06747091 · Stavros E Mountantonakis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with symptomatic persistent atrial fibrillation (an irregular heart rhythm lasting longer than 7 days but less than 12 months), confirmed by a doctor's notes and a heart tracing (ECG). - People who have been assessed as a suitable candidate for a ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06753045 · Tulane University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with at least one of the following conditions: heart failure, irregular heart rhythms, chronic kidney disease, coronary artery disease, a previous stroke or mini-stroke (TIA), or diabetes. - People who visit a primary care provider for any reaso...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06754176 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are comfortable reading and writing in English - People who own a smartphone and are willing and able to use a specific mobile app called Eureka - People who have been diagnosed with a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib), where...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06762717 · Boston Scientific Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People whose doctor has decided they should be treated with the FARAPULSE™ Pulsed Field Ablation system for heart tissue ablation, in line with the hospital's standard care practices - People who are willing and able to give their informed consent to take part - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06768528 · University of Sao Paulo General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2025
🇧🇷 BR

Who might be able to join this trial: - People who are scheduled to have coronary artery bypass graft (heart bypass) surgery Who may not be able to join: - People who are unable to sign a consent form agreeing to take part in the study - People with significant kidney problems, where the kidneys are working at a reduc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06784466 · Arga Medtech SA Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇧🇪 BE🇭🇷 HR🇨🇿 CZ🇱🇹 LT🇳🇱 NL🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 80 years old (or over 18 if local rules require it). - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) that keeps coming back and has not been controlled by medication — either episodes that last less than 7 days (paroxysm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06791915 · Kocaeli City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - People who are planned to have a procedure called radiofrequency ablation carried out under general anesthesia (fully asleep) - People who are 18 years of age or older Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06798714 · Tomsk Cardiology Research Institute Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 20 July 2025
🇷🇺 RU

Who might be able to join this trial: - People who are scheduled for a planned (non-emergency) heart bypass surgery that uses a heart-lung bypass machine. - People who are willing to sign a consent form agreeing to take part in the study. Who may not be able to join: - People whose heart's main pumping chamber is sign...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06800781 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇸🇪 SE

Who might be able to join this trial: - People aged 18 or older - People scheduled for a non-urgent heart operation, where at least 24 hours pass between the decision to operate and the actual surgery — specifically procedures involving coronary artery bypass grafting, aortic valve replacement, aortic surgery (without...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06801392 · Charles University, Czech Republic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇿 CZ

Who might be able to join this trial: - You have atrial fibrillation (an irregular heartbeat) that is not the "paroxysmal" type, meaning it does not come and go in short episodes but is more persistent or permanent - Your doctor has recommended a procedure called catheter ablation to treat your atrial fibrillation, in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06823778 · Vasily I. Kaleda Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇷🇺 RU

Who might be able to join this trial: - People who are having heart surgery performed by a specific surgeon (identified as V.K. in the trial) - People who have given their informed consent to take part in the trial Who may not be able to join: - People who have a history of an irregular heart rhythm condition called a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06825104 · Volta Medical Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇫🇷 FR🇩🇪 DE

Who might be able to join this trial: - You must have previously taken part in the "Tailored AF" study - You must have stayed in the Tailored AF study for the full 12-month follow-up period after your procedure without withdrawing - You must be willing and able to sign a consent form agreeing to take part in this exten...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06828939 · CardioFocus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇨🇿 CZ

**Who might be able to join this trial:** - You have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) that keeps coming back and is causing symptoms, with at least one recorded episode. - You have tried at least one medication to control your heart rhythm, but it ei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06832033 · Marcos Echevarría Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇸 ES

Who might be able to join this trial: - People aged 18 years or older - People who have had a catheter ablation procedure as treatment for atrial fibrillation (an irregular heart rhythm) at least one year before joining the trial Who may not be able to join: - People who do not sign the consent form agreeing to take p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06833138 · French Cardiology Society Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 May 2029
🇧🇪 BE🇫🇷 FR

**Who might be able to join this trial:** - You have been diagnosed with permanent atrial fibrillation (an irregular heart rhythm) lasting more than 6 months - Your heart's pumping strength is at or above a normal level (at least 50%) - You have been hospitalised at least once for heart failure in the past year - Your...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06842147 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2028
🇨🇳 CN

Who might be able to join this trial: - People aged 60 years or older - People who have never been diagnosed with atrial fibrillation (an irregular heartbeat condition) - People who are willing to be randomly assigned to a study group and attend follow-up appointments Who may not be able to join: - People who have a p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06844227 · McMaster University Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇦 CA🇬🇷 GR🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who have atrial fibrillation or atrial flutter (in any form — ongoing, long-lasting, or coming and going) that requires blood-thinning medication - People currently taking warfarin (with a target INR of 2.0–3.0) or one of the following blood thinners a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06847932 · National Defense Medical Center, Taiwan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇹🇼 TW

Who might be able to join this trial: - People who are either admitted to a hospital or attending as an outpatient. - People who have had at least one electrocardiogram (a heart tracing test, often called an ECG) within the past year. Who may not be able to join: - People who have been diagnosed with atrial fibrillati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06861673 · Asklepios proresearch Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇩🇪 DE

Who might be able to join this trial: - People who have a medical need for both a pulmonary vein isolation procedure (a heart rhythm treatment for atrial fibrillation) and a left atrial appendage closure procedure (a procedure to reduce stroke risk by closing off a small pouch in the heart) Who may not be able to join...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06871228 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇨🇳 CN

Who might be able to join this trial: - Adults between 18 and 80 years of age - People who had a heart rhythm procedure (ablation for atrial fibrillation or atrial flutter) roughly 2 to 12 months ago (within a specific time window around that range) - People with a heart stroke-risk score called CHA2DS2-VA of 2 or high...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06876896 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇺🇸 US

Who might be able to join this trial: - Adults who are having a specific heart procedure called pulse field ablation to treat an irregular heart rhythm (atrial fibrillation and/or atrial flutter) as part of their normal medical care. - People for whom a bladder catheter (a thin tube inserted into the bladder to drain u...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06883864 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 80 years old - People who have been diagnosed with persistent atrial fibrillation (an ongoing irregular heart rhythm), confirmed by a heart tracing (ECG) - People who have moderate-to-severe or worse leaking of the mitral heart valve (specifically a type li...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06903845 · Dong-Ju Choi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇰🇷 KR

**Who might be able to join this trial:** - You are 19 years old or older and have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - You have at least one of the following health conditions: heart failure, high blood pressure, coronary artery disease (blocked arteries in the heart), periphera...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06906432 · Beijing Tiantan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2034
🇨🇳 CN

**Who might be able to join this trial:** - People who are 18 years of age or older at the time of joining the trial - People who have had a confirmed bleed in the brain (shown by a brain scan such as a CT or MRI) within 48 hours of symptoms starting - People who are able to give consent themselves, or who have a legal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06935591 · Vektor Medical Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇩🇪 DE🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with persistent (but not long-standing) atrial fibrillation (an irregular heart rhythm), or recurring atrial fibrillation, as defined by this study's criteria. - People who have recent heart electrical activity recordings (ECGs) from their atri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06938412 · Icahn School of Medicine at Mount Sinai Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 40 years of age or older - People who have paroxysmal atrial fibrillation (AF), meaning a type of irregular heartbeat that comes and goes - People who have a recorded episode of AF (shown on a heart tracing or equivalent test) within the past 12 months — if som...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06949319 · Nedim Tojaga Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇩🇰 DK

**Who might be able to join this trial:** - You have been recently diagnosed with a type of irregular heartbeat called atrial fibrillation that is not caused by a heart valve problem. - You have never taken blood-thinning tablets (anticoagulants) before joining the trial. - You are 18 years old or older. - You are will...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06951100 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇬🇧 GB

Who might be able to join this trial: - Adults aged 18 years or older - People whose main reason for seeking care is symptoms caused by atrial fibrillation (an irregular heartbeat condition) - People whose heart is beating faster than 100 beats per minute due to atrial fibrillation, as shown on a heart tracing test (EC...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06953726 · VA Office of Research and Development Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 4 October 2032
🇺🇸 US

Who might be able to join this trial: - People who are Veterans, male or female, aged 22 years or older - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) or atrial flutter (a related heart rhythm condition) and are currently taking either apixaban or rivaroxaban (blood thinners) - Peopl...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06957366 · McMaster University Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇧🇪 BE🇨🇦 CA🇬🇷 GR🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who have atrial fibrillation, atrial flutter, or a blood clot condition (such as a clot in the leg or lungs), and who are taking a full-strength dose of one of these blood thinners: apixaban, dabigatran, edoxaban, or rivaroxaban (at specific doses suited t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06958029 · Khon Kaen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇹🇭 TH

Who might be able to join this trial: - You are 18 years of age or older - You are having heart valve surgery or a coronary artery bypass grafting (CABG) procedure, which is a surgery to improve blood flow to the heart Who may not be able to join: - You are having surgery on the aorta (the main large artery coming fro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06959121 · Pulse Biosciences, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 85 years old - People who are willing and able to give informed consent and attend all required follow-up visits as set out in the study plan - People who have a documented history of atrial fibrillation (an irregular heart rhythm) — either the typ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06960252 · Ting-Yung Chang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇹🇼 TW

Who might be able to join this trial: - People who have agreed to take part by signing a consent form and are willing to be monitored during the study. - People who have atrial fibrillation (an irregular heart rhythm) that has not responded to, or could not be tolerated, at least one type of heart rhythm medication (Cl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06973031 · Kardium Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇩🇪 DE

**Who might be able to join this trial:** - You have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes or is ongoing, and it causes symptoms that keep coming back - You have already tried at least one medication used to control heart rhythm (a type called Class I or III antiarrhythmic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06983613 · Na Homolce Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇿 CZ

Who might be able to join this trial: - People who have had a stroke and where a team of heart and brain specialists has agreed that closing a small natural opening in the heart (called a patent foramen ovale, or PFO) is the right treatment, following current medical guidelines. - People who are older than 18 years of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06984731 · Affiliated Hospital of Nantong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years of age or older and have been diagnosed with atrial fibrillation that is not caused by a heart valve problem - Your doctor has determined that you are a suitable candidate for both a left atrial appendage closure procedure (using the WATCHMAN FLX device) and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06985901 · Centre Hospitalier Universitaire de Nice Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 April 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who have persistent atrial fibrillation (an irregular heart rhythm that has continued without stopping for more than 7 days) and are experiencing symptoms from it - People who have tried heart rhythm medications but found them ineffective, had bad side effects, or do n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06987825 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2035
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 years or older. - People who have had a recorded episode of atrial fibrillation (an irregular heart rhythm) lasting longer than 30 seconds, confirmed by a heart tracing device such as an ECG, a Holter monitor, an implanted heart monitor, or a wearable ECG devic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06989580 · Biotronik SE & Co. KG Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇧🇪 BE🇩🇪 DE

Who might be able to join this trial: - People who have been diagnosed with heart failure for at least 90 days and are currently experiencing moderate symptoms (not the most mild, but not the most severe) - People who, in the past year, were admitted to hospital with worsening heart failure as the main reason for admis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06989775 · AtriCure, Inc. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People who are already scheduled and medically approved for open-heart surgery that requires the use of a heart-lung bypass machine and opening of the sac surrounding the heart. - People who are 65 years of age or older and have a stroke risk score (called CHA2DS2-VASc) of 3 or h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06995391 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2030
🇺🇸 US

Who might be able to join this trial: - People who are 21 years of age or older - People who own a smartphone - People who are able to use the Eureka mobile app - People who have a history of atrial fibrillation (an irregular heart rhythm) that comes and goes or has been ongoing for a period of time - People who have d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07002450 · Ottawa Heart Institute Research Corporation Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 15 June 2028
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have atrial fibrillation (an irregular heartbeat) that causes symptoms and is not caused by a temporary or treatable condition such as an infection, a blood clot in the lungs, or an overactive thyroid - People whose doctors, fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07018596 · Pulse Biosciences, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇿 CZ

**Who might be able to join this trial:** - People who have been diagnosed with recurring, drug-resistant paroxysmal atrial fibrillation (a type of irregular heartbeat that starts and stops on its own or with treatment within 7 days), with at least two episodes recorded by a doctor in the past 6 months - People aged 1...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07018648 · KARDI AI Technologies s.r.o. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇨🇿 CZ

Who might be able to join this trial: - People who are 18 years of age or older - People who are willing to participate and have signed a consent form - People who have a confirmed or suspected heart rhythm problem - People who are able to use a smartphone and a mobile app called Kardi Ai - People whose smartphone meet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07021313 · R&D Cardiologie Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇳🇱 NL

Who might be able to join this trial: - People who are already scheduled to have a heart rhythm procedure called pulmonary vein isolation (PVI) using a specific device called the FARAPULSE catheter ablation system - People who have been diagnosed with a type of irregular heartbeat called paroxysmal atrial fibrillation...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07024927 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2032
🇨🇳 CN

**Atrial Fibrillation (AF) Group** Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm), including types that come and go or that persist over time - People who are scheduled to have their first-ever cathet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07042529 · Ole De Backer Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2029
🇧🇪 BE🇩🇰 DK🇫🇮 FI🇳🇱 NL🇳🇴 NO🇸🇪 SE

**Who might be able to join this trial:** - You have been diagnosed with severe aortic stenosis (a serious narrowing of a heart valve) that is causing symptoms, and your doctors have recommended a procedure called TAVI (a minimally invasive heart valve replacement) - You are able to understand and follow the study inst...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07047235 · Barts & The London NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 18 November 2029
🇬🇧 GB

Who might be able to join this trial: - People who are willing and able to sign a written consent form agreeing to take part - People who are 18 years of age or older - People who have been diagnosed with persistent atrial fibrillation (a type of irregular heartbeat that does not stop on its own) - People who are alrea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07058831 · Cardiovascular Research Center Rosario British Sanatorium Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇦🇷 AR

**Who might be able to join this trial:** - People of any sex who have high blood pressure and are older than 75 years of age - People with high blood pressure who are between 65 and 75 years old and also have at least one of the following conditions: - Obesity - Type 2 diabetes - Obstructive sleep apnea (breath...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07064616 · Kitasato University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇯🇵 JP

Who might be able to join this trial: - People between 18 and 85 years of age - People who have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm that has lasted less than one year, or that has needed a procedure to restore normal rhythm) - People whose condition meets the current Japanese m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07085650 · First Hospital of China Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2025
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have come to hospital with atrial fibrillation (an irregular heartbeat condition) and are planning to have an ablation procedure (a treatment that uses energy to correct the abnormal heart rhythm) Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07095959 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 July 2027
🇨🇳 CN

Who might be able to join this trial: - You are 18 years of age or older - You have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) and experience symptoms such as palpitations, dizziness, fatigue, shortness of breath, or chest discomfort - This would be your first...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07106970 · Boston Scientific Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 80 years old. - People who have persistent atrial fibrillation (an irregular heart rhythm lasting more than 90 days) that causes symptoms such as palpitations, near-fainting, fainting, tiredness, or shortness of breath. - People whose atrial fibrillatio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07109141 · Wroclaw Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇵🇱 PL

Who might be able to join this trial: - The person must have given their informed consent to take part in the trial - The person must be undergoing a heart procedure called ablation (a treatment that uses energy to correct irregular heart rhythms) using a specific technology called pulsed field ablation (PFA) Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07118046 · Daniel Rodríguez Muñoz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇪🇸 ES

**Who might be able to join this trial:** - You are 18 years old or older - You have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF), either the kind that comes and goes or the kind that lasts longer - Your doctor has recommended a procedure to treat your heart's irregular rhythm, spec...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07122336 · Shanghai Chest Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have never had an ablation procedure for their heart rhythm condition before - People whose atrial fibrillation (an irregular heartbeat) has lasted for episodes of at least 7 days but no longer than 3 years continuously, includ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07122947 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

Who might be able to join this trial: - People who are 22 years of age or older - People who have a documented or current history of atrial fibrillation (an irregular heart rhythm condition), including any type — paroxysmal (comes and goes), persistent, or long-standing persistent - People who are scheduled to have pla...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07125417 · OCEAN-SHD Study Group Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 May 2029
🇯🇵 JP

**Who might be able to join this trial:** - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) that is not caused by a faulty or mechanical heart valve - People whose stroke risk score (called CHA2DS2-VA) is 2 or higher, indicating a moderate to high risk of stroke - People who meet the m...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07129564 · Yuehui Yin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 November 2024
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 80 years old who have persistent atrial fibrillation (an irregular heartbeat that doesn't stop on its own) along with an enlarged left chamber of the heart (measured at a specific size range) - People who are willing to have their heart rhythm reset (ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07130773 · Cardiocentro Ticino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇨🇭 CH

**Who might be able to join this trial:** - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm), confirmed by a heart tracing test, a portable heart monitor, or an implanted heart device - People whose doctor has determined that a procedure to correct the irregular heart rhythm (called a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07141745 · Wroclaw Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇵🇱 PL

Who might be able to join this trial: - People who have had atrial fibrillation (AF) or an irregular heart rhythm called atypical atrial flutter return after a previous procedure to treat it (called pulmonary vein isolation, or PVI) - People whose heart condition makes them suitable for a repeat pulmonary vein isolatio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07149688 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2035
🇨🇳 CN

Who might be able to join this trial: - People who are 60 years of age or older - People who live in the Qujiang District - People who have been diagnosed with a long-term heart or blood vessel condition, such as high blood pressure, coronary artery disease, heart failure, irregular heartbeat (atrial fibrillation), or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07156877 · Sebastien Knecht Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇧🇪 BE

**Who might be able to join this trial:** - People who have a type of irregular heart rhythm called atrial fibrillation (AF) — either one that comes and goes, or one that is ongoing — confirmed by a heart tracing test (ECG) or a monitoring device within the past 24 months, with the episode lasting at least 30 seconds....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07171463 · St. Joseph's Centre, Poland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇵🇱 PL

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) and have had at least one episode lasting 30 seconds or more, confirmed by a heart monitor test - People who are willing a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07173855 · Scarborough General Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2027
🇨🇦 CA

Who might be able to join this trial: - People aged 16 years or older - People who have been admitted to a medical-surgical intensive care unit at a hospital taking part in the trial - People for whom a magnesium replacement treatment plan has been ordered by their medical team Who may not be able to join: - People wh...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07173998 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

"Who might be able to join this trial: - Adults of any gender between 18 and 99 years old - People who are scheduled to have heart surgery - People who are able to answer survey questions Who may not be able to join: - People who have a type of irregular heartbeat called persistent or permanent atrial fibrillation - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07174206 · University of Sao Paulo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇧🇷 BR

**Who might be able to join this trial:** - You have been diagnosed with a heart or blood vessel (cardiovascular) condition, are male or female, and are older than 22 years of age - You are willing and able to sign a consent form agreeing to take part in the study - You agree to follow the study's procedures and requir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07181590 · Abbott Medical Devices Not Applicable · 12 countries Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇦🇹 AT🇧🇪 BE🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇪 IE🇮🇹 IT🇳🇱 NL +4 more

**Who might be able to join this trial:** - People who have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that starts and stops on its own) or persistent atrial fibrillation (an irregular heartbeat lasting more than 7 days but less than 1 year), confirmed by a doctor's note and hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07187115 · Boston Scientific Corporation Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇧🇪 BE🇫🇷 FR🇩🇪 DE Hong Kong🇳🇱 NL🇪🇸 ES🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older (or older if local laws require it) - People who have persistent atrial fibrillation (an irregular heart rhythm lasting more than 7 days but no longer than 365 days) that causes symptoms and has not responded to medication, confirmed by medical record...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07187570 · Region Stockholm Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇸🇪 SE

**Who might be able to join this trial:** - People who have an irregular heart rhythm called atrial fibrillation (AF) that has been confirmed on a heart tracing (ECG), and who are already scheduled to have a procedure called electrical cardioversion (a controlled electric shock to reset the heart's rhythm) between 7 an...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07196176 · Heinrich-Heine University, Duesseldorf Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇩🇪 DE

Who might be able to join this trial: - People who have already had a heart rhythm test (called an electrophysiological study) or an electric shock treatment to restore normal heart rhythm (called electrical cardioversion) at University Hospital Düsseldorf since 2015 (for the past records part of the study) - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07210151 · LUMA Vision Ltd. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇭🇷 HR🇨🇿 CZ

Who might be able to join this trial: - People who are at least 18 years old at the time of giving consent - People who are scheduled to have a catheter ablation procedure to treat atrial flutter or atrial fibrillation (irregular heart rhythms), as recommended by their doctor and in line with current medical guidelines...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07217067 · Novartis Pharmaceuticals Phase 2 · 7 countries Recruiting
Recruiting Phase 2 Est. completion 9 September 2027
🇨🇦 CA🇨🇳 CN🇩🇪 DE🇳🇱 NL🇸🇬 SG🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older (male or female) - You have had at least 2 episodes of atrial fibrillation (AF) or atrial flutter, and at least one of those must have been atrial fibrillation specifically - At least one of those AF episodes happened within the last 12 month...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07220525 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People who are 21 years of age or older - People who have had a specific implanted device (called an HGNS device) placed to treat obstructive sleep apnea, and who are followed up at UCSF Health - People who are willing to temporarily stop using their upper airway stimulation devi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07227532 · Biosense Webster, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) and are experiencing symptoms from it, where their doctor considers them a suitable candidate for a catheter ablation procedure (a procedure to correct the irregul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07236619 · Erasmus Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇳🇱 NL

**Who might be able to join this trial:** - People who have been diagnosed with paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) and have experienced symptoms from it - People whose heart specialist has determined that a procedure to isolate the pulmonary veins (the main electrical pathways i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07253974 · Parc de Salut Mar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 November 2026
🇪🇸 ES

**Who might be able to join this trial:** - You are 18 years of age or older - You have had your first-ever stroke caused by a blocked blood vessel in the brain (ischemic stroke) **Who may not be able to join:** - You have bleeding in the brain (intracranial haemorrhage) - Your stroke has led to bleeding complications...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07262255 · Boston Scientific Corporation Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇩🇰 DK🇩🇪 DE🇮🇹 IT🇵🇱 PL🇪🇸 ES🇨🇭 CH

**Who might be able to join this trial:** - You are scheduled to receive treatment with the WATCHMAN FLX™ Pro device, which is used to close off a small pouch in the heart. - You have a type of irregular heartbeat called atrial fibrillation that is not caused by a problem with your heart valve, and your doctor has reco...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07267949 · Acesion Pharma Phase 2 · 8 countries Recruiting
Recruiting Phase 2 Est. completion 1 November 2026
🇧🇬 BG🇩🇰 DK🇩🇪 DE🇭🇺 HU🇮🇹 IT🇳🇱 NL🇵🇱 PL🇷🇸 RS

Who might be able to join this trial: - People who are willing and able to sign a written consent form agreeing to take part. - People who are 18 years of age or older. - People who have been diagnosed with a type of irregular heart rhythm called atrial fibrillation (AF), confirmed by a heart tracing (ECG), where episo...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07270757 · Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 70 years old - People who are scheduled to have their first ablation procedure for atrial fibrillation (a heart rhythm condition) - People whose heart failure symptoms are mild or absent, meaning day-to-day activities are not significantly limited (conf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07271238 · LUMA Vision Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2026
🇭🇷 HR

Who might be able to join this trial: - People who are at least 18 years old at the time of signing the consent form - People who are already scheduled to have a catheter ablation procedure to treat atrial flutter (AFL) or atrial fibrillation (AF), as recommended by their doctor following standard medical guidelines -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07272902 · Nova Scotia Health Authority Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇨🇦 CA

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm), confirmed by a heart monitoring test such as a Holter monitor, rhythm strip, or ECG - People with moderate heart failure symptoms, classified as NYH...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07275151 · CathVision ApS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇺🇸 US

Who might be able to join this trial: - People who are having their first-ever procedure to isolate the pulmonary veins (the veins connecting the lungs to the heart) as a treatment for atrial fibrillation (an irregular heartbeat condition). - People who are male or non-pregnant female, aged 21 years or older. - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07278089 · Tze-Fan Chao Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2031
🇹🇼 TW

**Who might be able to join this trial:** - Your left atrium (a chamber in your heart) is enlarged, based on measurements taken during a heart scan - The walls of your heart's main pumping chamber are thicker than normal (15mm or more) - A specific measurement from your heart ultrasound (called E/e') is above 14, whic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07278869 · Append Medical Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who are male or not currently pregnant - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that is not caused by a damaged heart valve - People whose AF-related stroke risk score meets a certain threshol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07281521 · CardioFocus Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇭🇷 HR🇨🇿 CZ

**Who might be able to join this trial:** - People diagnosed with recurrent symptomatic paroxysmal atrial fibrillation (AF that starts and stops on its own) or persistent atrial fibrillation (AF that continues unless treated), with documented proof of episodes within the past 12 months - People with persistent AF who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07281898 · Zhibing Lu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2028
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 80 years old - You have been diagnosed with a type of irregular heartbeat called paroxysmal atrial fibrillation, where episodes stop on their own and last less than 7 days - You are scheduled to have your first-ever procedure (called radiofrequency cath...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07287345 · Ayesha Ather Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You are scheduled to have a planned heart bypass surgery (where surgeons use blood vessels to reroute blood around blocked arteries in the heart) **Who may not be able to join:** - You have a history of an irregular heart rhythm condition c...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07301190 · The Third People's Hospital of Chengdu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 75 years old (either gender) - You have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm lasting more than 7 days) that is causing symptoms - Your medical records show evidence of this ongoing irregular heart rhythm, either...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07308847 · Medtronic Cardiac Ablation Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 November 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with recurring paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes), where episodes last more than 30 seconds but stop on their own or with treatment within 7 days, with at least 2 symptomatic episodes recorded by a doc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07316231 · Toho University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇯🇵 JP

"Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with atrial fibrillation or a fast abnormal heart rhythm (called atrial tachycardia), and whose heart is either currently in a normal rhythm or can be confirmed to be in a normal rhythm at the time of the h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07316270 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇨🇳 CN

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have had a spontaneous brain bleed (not caused by injury) between 14 days and 12 months before joining the trial - People for whom brain scan images from their brain bleed are available for the trial team to review - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07320560 · German Heart Institute Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇩🇪 DE🇵🇹 PT🇪🇸 ES

Who might be able to join this trial: - People who have persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) and have not previously had a catheter ablation procedure for it, and are now planned to have one - People whose left atrium (one of the heart's chambers) is enlarged, as measu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07344961 · Northwell Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - You (or a legal representative on your behalf) are willing and able to give consent to take part, following the rules of the institution and location - You have already received a Micra AV2 device (a small, wireless pacemaker) or are planned to receive one as part of your nor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07347691 · Inha University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇰🇷 KR

Who might be able to join this trial: - People who are 30 years of age or older. - People who have been diagnosed with a stroke where the cause could not be determined (called Embolic Stroke of Undetermined Source), and who have already had, or are planned to have, a small heart-monitoring device implanted under the sk...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07349121 · Boston Scientific Corporation Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇭🇷 HR🇫🇷 FR🇪🇸 ES

**Who might be able to join this trial:** - People whose doctor has determined they need treatment with both the FARAPULSE™ pulse field ablation system and a WATCHMAN FLX™ Pro or WATCHMAN FLX™ left atrial appendage closure device, based on their hospital's standard care guidelines. - People who are willing and able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07353775 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2026
🇨🇳 CN

Who might be able to join this trial: - People diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes, or that is ongoing - People aged 18 years or older - People who are already scheduled to have a specific heart procedure called CTI ablation (a procedure that uses heat or cold energy to corre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07358611 · Hospital Clinic of Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

Who might be able to join this trial: - People who have persistent atrial fibrillation (an irregular heart rhythm that does not stop on its own) and have not previously had a catheter ablation procedure for it, and are now planned to have one - People whose left atrium (one of the heart's upper chambers) is enlarged, b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07360899 · Institute of Cardiovascular Diseases, Vojvodina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇷🇸 RS

Who might be able to join this trial: - People aged 18 years or older - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition), of any type - People with a stroke risk score of 2 or higher, measured using a standard scoring tool called CHA₂DS₂-VASc, or who have a similar level of str...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07363278 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇰🇷 KR

**Who might be able to join this trial:** - People who are having a heart rhythm procedure (atrial fibrillation ablation) using a specific device called the Varipulse™ catheter **Who may not be able to join:** - People who are under 19 years of age - People who also have a different type of heat-based ablation treatme...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07385599 · Lifetech Scientific (Shenzhen) Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
Hong Kong

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) that is paroxysmal (comes and goes), persistent, or permanent, and is not caused by a heart valve problem - People whose doctors have calculated a stroke risk...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07389434 · University Hospital Dubrava Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2027
🇭🇷 HR

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with a type of irregular heart rhythm called atrial fibrillation — either the kind that comes and goes (paroxysmal) or the kind that lasts longer (persistent) — confirmed by a heart rhythm test such as an EC...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07390175 · Hospital San Carlos, Madrid Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

Who might be able to join this trial: - Adults aged 18 or older who have had persistent atrial fibrillation (an irregular heart rhythm that has continued without stopping) for more than 6 months, and whose doctor has recommended a procedure to treat it using ablation (a technique that targets abnormal heart tissue). -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07390214 · Cardioangiologisches Centrum Bethanien Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇩🇪 DE

Who might be able to join this trial: - You have been diagnosed with atrial fibrillation (AF) or a related irregular heart rhythm (atrial tachycardia) that is causing symptoms, and these symptoms have come back after already having one catheter ablation procedure to treat AF - You are between 18 and 85 years old - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07403760 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2028
🇨🇳 CN

**Who might be able to join this trial:** - People who are 80 years of age or older - People who have had a confirmed diagnosis of atrial fibrillation (an irregular heartbeat) shown on a heart tracing test (ECG) or a monitoring device (Holter monitor) within the past 6 months - People who experience symptoms related t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07405359 · Edward Gerstenfeld, MD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 August 2028
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older at the time of their pre-procedure visit - People who have persistent atrial fibrillation (an irregular heart rhythm that has lasted continuously for at least 7 days), confirmed by a continuous heart monitor, two heart tracings (ECGs) taken...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07407790 · Sorlandet Hospital HF Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇳🇴 NO

**Who might be able to join this trial:** - You have been admitted to hospital with a stroke or a mini-stroke (sometimes called a TIA), which happened within the last 2 weeks. - Brain scans (such as a CT scan or MRI) support the diagnosis of a stroke or mini-stroke. - You have a smartphone and are able to use an app ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07414121 · Asklepios proresearch Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇩🇪 DE

Who might be able to join this trial: - People who are undergoing or have undergone a procedure to treat an irregular heart rhythm condition called atrial fibrillation (AF), known as ablation therapy Who may not be able to join: - People under 18 years of age Important: Always verify eligibility with the trial site d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07421076 · Abbott Medical Devices Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 November 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are at least 18 years old - People who have given written consent to participate before any trial-related procedures take place - People who have been diagnosed with symptomatic paroxysmal atrial fibrillation (a type of irregular heartbeat that starts and stops on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07428564 · Biosense Webster, Inc. Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇧🇪 BE🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇹 IT🇱🇹 LT🇳🇱 NL

Who might be able to join this trial: - People who have been diagnosed with symptomatic persistent atrial fibrillation (an irregular heart rhythm that causes symptoms and has lasted a certain period of time) - People whose doctor has chosen a procedure called pulmonary vein isolation (a type of heart ablation) to treat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07428967 · St. Josefs-Hospital Wiesbaden GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇩🇪 DE

**Who might be able to join this trial:** - People who have atrial fibrillation (an irregular heartbeat) that causes significant symptoms, and whose condition has not been controlled well enough with standard medications or procedures - People whose heart pumping function is within the normal range (confirmed by an ul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07429214 · Biosense Webster, Inc. Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇧🇪 BE🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇹 IT🇱🇹 LT🇳🇱 NL

Who might be able to join this trial: - People who have been diagnosed with symptomatic persistent atrial fibrillation (an irregular heartbeat that is ongoing) or paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) - People whose doctor has chosen a specific heart procedure called pulmonary vein...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07434674 · University of California, San Diego Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: - People who already have a medical reason to have a small heart-monitoring device (called an insertable cardiac monitor) placed under their skin as part of their normal care. - People who are scheduled to receive, or have already received, a specific heart monitor called the Bosto...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07439016 · Charles University, Czech Republic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇨🇿 CZ

Who might be able to join this trial: - Adults aged 18 years or older - People who have a type of irregular heartbeat that comes and goes (called paroxysmal atrial fibrillation), and whose heart is in a normal rhythm at the start of the procedure Who may not be able to join: - People whose irregular heartbeat is conti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07441382 · Guangdong Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇳 CN

Who might be able to join this trial: - You are 75 years old or older - You have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that is not caused by a heart valve problem - Your doctor has calculated that you have a high risk of stroke based on a standard scoring system (a score of 3...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07442175 · Andon Health Co., Ltd Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 22 years or older - People whose upper arm measures between 22 cm and 42 cm around - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) by a doctor or medical institution, OR people who have never been diagnosed with atrial fibrillati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07444931 · Tampere Heart Hospital Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇮🇱 IL Moldova🇷🇴 RO

Who might be able to join this trial: - You must be 18 years of age or older - You must be able to understand and agree to take part in the study by giving your consent - You must have had a scan or procedure in the past 12 months (such as a coronary angiogram or a special CT heart scan) that confirmed a diagnosis of s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07458191 · Bosnalijek D.D Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
Bosnia and Herzegovina

**Who might be able to join this trial:** - People who are 18 years of age or older - People whose heart and circulation are stable (not in a state of shock or collapse) - People who have a type of irregular heartbeat called atrial fibrillation that is not caused by a problem with the heart valves - People whose doctor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07459387 · Cardioangiologisches Centrum Bethanien Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 October 2027
🇩🇪 DE

Who might be able to join this trial: - People who are 18 years of age or older - People who have undergone an atrial fibrillation (AF) catheter ablation procedure using a specific new device called the VOLT PFA balloon-in-basket system - People who are able and willing to give their consent to participate Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07490808 · Beijing Anzhen Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older. - People who have been diagnosed with symptomatic paroxysmal atrial fibrillation (an irregular heart rhythm that starts and stops on its own or with treatment within 7 days), with at least 2 symptomatic episodes in the past 6 months and at least 1 ep...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07492524 · Jiangsu Taizhou People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2029
🇨🇳 CN

Who might be able to join this trial: - The trial is based at village clinics that are willing and able to provide coordinated care to patients with atrial fibrillation (an irregular heart rhythm condition) - The village clinic serving the patient must cover patients from 3 to 5 nearby villages, with doctors trained in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07498283 · University College Copenhagen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇩🇰 DK

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - People whose highest level of education is vocational training or below, as a way of identifying those from lower socioeconomic backgrounds - People who can understand an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07501299 · HeartBeam, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - People who are already having an ECG (a heart tracing test) as part of their usual medical care. - People who are able and willing to sign a written consent form agreeing to take part. Who may not be able to join: - People who have open chest wounds, or who have had surgery on t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07508618 · Sir Run Run Shaw Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 August 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 80 years old (inclusive) - You have been diagnosed with a specific type of irregular heartbeat called non-valvular persistent atrial fibrillation, at least one medication to control the heart rhythm has not worked for you, and you are scheduled to have...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07515040 · Second Affiliated Hospital of Nanchang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 February 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 75 years old (inclusive) - You have been diagnosed with atrial fibrillation (an irregular heartbeat condition), your doctor has recommended a procedure called radiofrequency ablation, and you are already scheduled to have it - You are willing to take pa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07518966 · West China Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 June 2026
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition) and are already scheduled to have a procedure called pulsed field ablation (a type of heart rhythm treatment) - People who have never previously ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07521800 · Medical University of Silesia Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇮🇹 IT🇵🇱 PL

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with severe narrowing of the aortic heart valve (severe aortic stenosis) - A medical team has assessed you as being at moderate or high risk from heart-related complications, and has recommended you for a procedure ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07523620 · Abbott Medical Devices Not Applicable · 10 countries Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇧🇪 BE🇨🇿 CZ🇩🇰 DK🇩🇪 DE🇮🇪 IE🇮🇹 IT🇱🇹 LT🇵🇱 PL +2 more

Who might be able to join this trial: - People who are 18 years of age or older (or the legal age of consent in their region) - People with a stroke risk score (called CHA2DS2-VASc) of 2 or more for men, or 3 or more for women - People whose doctor expects them to be able to stop blood-thinning medication within 90 day...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07523750 · Biosense Webster, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with symptomatic persistent atrial fibrillation (an irregular heartbeat that has continued non-stop for more than 7 days but less than 365 days), confirmed by a doctor's notes and at least two heart tracings (ECGs) taken at least 7 days apart,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07527299 · Biosense Webster, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2028
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with symptomatic persistent atrial fibrillation (an irregular heart rhythm that has lasted more than 7 days but less than 365 days), confirmed by a doctor's note and either two heart tracings (ECGs) taken at least 7 days apart, or a 24-hour heart mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07535268 · Vivek Reddy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇺🇸 US

**Who might be able to join this trial:** - You identify as a racial or ethnic minority and are scheduled to have a heart rhythm procedure (called ablation) for atrial fibrillation (AF) using a specific approved device made by Boston Scientific - You have been diagnosed with symptomatic AF that comes and goes (paroxysm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07563257 · Maxime Zabern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇮🇱 IL

Who might be able to join this trial: - People who are 18 years of age or older. - People who have been diagnosed with a type of irregular heart rhythm called persistent atrial fibrillation and/or atrial flutter. - People who are already scheduled to have a heart procedure called catheter ablation (either for the first...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07569016 · Istanbul University - Cerrahpasa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) and are scheduled for a planned procedure to restore normal heart rhythm using an electrical shock - People whose overall physical health is rated as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07575269 · Boston Scientific Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 June 2028
🇺🇸 US

Who might be able to join this trial: - People who are at least 18 years old (or older if local laws require it) - People who have atrial fibrillation (an irregular heart rhythm) that causes symptoms, has been confirmed by medical testing, and has not been controlled by medication — either the type that comes and goes...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07580547 · Anat Milman Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 April 2027
🇮🇱 IL

Who might be able to join this trial: - People between 18 and 80 years old - People of any sex (male or female) - People who have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes or has been ongoing, and for whom doctors have recommended a heart procedure called catheter ablation for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07601763 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who have atrial fibrillation (an irregular heartbeat condition) and are planning to have a catheter ablation procedure - People who are 18 years of age or older - People who are able to understand and sign a consent form agreeing to take part **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07607093 · Samsung Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇰🇷 KR

Who might be able to join this trial: - You have both an irregular heart rhythm called atrial fibrillation (AF) and a leaky tricuspid heart valve (tricuspid regurgitation) at the same time Who may not be able to join: - You have had surgery on any of your heart valves in the past - You were born with a heart defect or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07611084 · Jiangsu Taizhou People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇨🇳 CN

**Who might be able to join this trial:** - You must be a permanent resident with a local household registration in a rural area of China. - You must be between 65 and 80 years old. - You must have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed either by a heart tracing test (ECG) or by an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07617974 · Centro Cardiologico Monzino Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇮🇹 IT

Who might be able to join this trial: - People who have atrial fibrillation (an irregular heart rhythm that comes and goes, or is ongoing) and are having a heart ultrasound before a procedure to treat their irregular heart rhythm. - People with a structurally normal heart and no history of atrial fibrillation may be el...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07618741 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2030
🇹🇼 TW

Who might be able to join this trial: - People who have a standard medical recommendation for a heart procedure called catheter ablation to treat a type of irregular heartbeat (atrial fibrillation that comes and goes, or has been ongoing), and who are scheduled to have this procedure at National Taiwan University Hospi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07620262 · Northwell Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older (or older if required by local laws) - People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that comes and goes, or that has lasted a long time, and is not caused by something temporary or r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07630857 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 September 2026
🇨🇳 CN

Who might be able to join this trial: - Adults aged between 18 and 80 years old - People who have a confirmed diagnosis of atrial fibrillation (an irregular heart rhythm), either the type that comes and goes or the type that stays for longer periods - People who are already scheduled to have a catheter ablation procedu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07641582 · Seoul St. Mary's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who have symptoms that could suggest an irregular heartbeat that comes and goes, such as occasional fluttering in the chest or chest discomfort - People aged 60 or older who have no symptoms but have at least one of the following health conditions or risk factors: high...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07684053 · Medical University Innsbruck Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2031
🇦🇹 AT

Who might be able to join this trial: - People who are 65 years of age or older - People who are registered with the Austrian social insurance system and have an active insurance number - People who are willing and able to give written electronic consent to take part Who may not be able to join: - People who are curre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07724171 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 4 May 2036
🇰🇷 KR

Who might be able to join this trial: - People aged 19 years or older - People who have had a patent foramen ovale (a small hole in the heart) closed using a minimally invasive procedure through the skin (rather than open-heart surgery) - For the retrospective (past records) group: people whose procedure was performed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Atrial Fibrillation. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

The Heart Foundation covers atrial fibrillation as part of its work on heart health.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.